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Résumé 
 
Afin d'étudier la diffusion et la libération de molécules de tailles inférieures dans un gel 
polymère, les coefficients d'auto-diffusion d'une série de polymères en étoile avec un noyau 
d'acide cholique et quatre branches de poly(éthylène glycol) (PEG) ont été déterminés par 
spectroscopie RMN à gradient de champ pulsé dans des solutions aqueuses et des gels de 
poly(alcool vinylique). Les coefficients de diffusion obtenus ont été comparés avec ceux des 
PEGs linéaires et dendritiques pour étudier l'effet de l'architecture des polymères. Les 
polymères en étoile amphiphiles ont des profils de diffusion en fonction de la concentration 
similaires à leurs homologues linéaires dans le régime dilué. Ils diffusent plus lentement dans 
le régime semi-dilué en raison de leur noyau hydrophobe. Leurs conformations en solution 
ont été étudiées par des mesures de temps de relaxation spin-réseau T1 du noyau et des 
branches. 
L'imagerie RMN a été utilisée pour étudier le gonflement des comprimés polymères et la 
diffusion dans la matrice polymère. Les comprimés étaient constitués d'amidon à haute teneur 
en amylose et chargés avec de l'acétaminophène (de 10 à 40% en poids). Le gonflement des 
comprimés, ainsi que l'absorption et la diffusion de l'eau, augmentent avec la teneur en 
médicament, tandis que le pourcentage de libération du médicament est similaire pour tous 
les comprimés. 
Le gonflement in vitro des comprimés d'un complexe polyélectrolyte à base d'amidon 
carboxyméthylé et de chitosane a également été étudié par imagerie RMN. Ces comprimés 
sont sensibles au pH : ils gonflent beaucoup plus dans les milieux acides que dans les milieux 
neutres en raison de la dissociation des deux composants et de la protonation des chaînes du 
chitosane. La comparaison des résultats avec ceux d'amidon à haute teneur en amylose 
indique que les deux matrices ont des gonflements et des profils de libération du médicament 
semblables dans les milieux neutres, alors que les comprimés complexes gonflent plus dans 
les milieux acides en raison de la dissociation du chitosane et de l'amidon.  
 
Mots-clés: RMN à gradient de champ pulsé, Imagerie RMN, Coefficients d'auto-diffusion, 
Polymère en étoile, Amidon à haute teneur en amylose, Chitosane 
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Abstract 
 
In an effort to study the diffusion and release of small molecules in a polymeric system, 
the self-diffusion coefficients of a series of star polymers with a cholic acid core bearing four 
poly(ethylene glycol) (PEG) arms in aqueous solutions and gels of poly(vinyl alcohol) were 
determined by pulsed gradient spin-echo NMR techniques. The results have been compared 
with those of linear and dendritic PEGs to elucidate the effect of the architecture of the 
polymers. The amphiphilic star polymers show similar concentration-dependent diffusion 
behaviors in the dilute regime to their linear homologues. They diffuse more slowly in the 
semi-dilute regime than the linear PEGs due to the presence of the hydrophobic core. The 
conformation of the star polymers in the solutions was studied by measuring the T1 values of 
the core and the arms of the diffusants. 
NMR imaging was used to study the swelling of polymeric tablets and diffusion in the 
polymer matrix. The tablets investigated were made of cross-linked high amylose starch 
(CHAS) and loaded with acetaminophen (10, 20 and 40 wt%). The swelling, water uptake 
and diffusion in the CHAS network are faster at higher drug loading levels, while the drug 
release rates are similar among all the tablets. 
The in vitro swelling of the tablets made of a polyelectrolyte complex based on chitosan 
and carboxymethylated starch has also been studied by NMR imaging. These tablets showed 
pH-sensitive behavior. They swelled much more in acidic media than in neutral media due to 
dissociation of the two components and the protonation of the amino groups in the chitosan 
residues. The comparison of the results with those obtained with the CHAS tablets indicates 
that the two matrices have similar swelling and drug release profile in neutral media, while 
the complex tablets showed a greater extent of swelling in acidic media due the dissociation 
of the chitosan from the complex. 
 
Keywords: Pulsed gradient NMR spectroscopy, NMR imaging, Self-diffusion coefficients, 
Star polymer, High amylose starch, Chitosan. 
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1. Introduction 
 
Polymers have been widely used as excipients in the field of drug delivery. The 
pharmaceutical polymers provide the researchers with a wide choice of physical and chemical 
characteristics such as different molecular weight and possibility of copolymerisation, 
modification or blending with other polymers.1 They include both natural polymers (such as 
starch, cellulose, chitosan, and pectin) and synthetic polymers (such as polyanhydrides, 
polyesters, polyacrylic acids, poly(methyl methacrylates), and polyurethanes). The wide 
range of physicochemical properties may be utilised to improve the clinical use, 
manufacturing, and stability of dosage forms.1 More specifically, polymers have been used as 
binders, flow-controlling agents, and coatings in the conventional solid and liquid dosage 
forms. They are also essential parts to modify release characteristics in sustained drug release 
formulations.2-4  
Drug dosage forms can be oral, inhalational, parenteral, topical, or suppository. Each of 
the forms has advantages and disadvantages. Different medical conditions or different drugs 
warrant different routes of administration. Around 84% of the 50 most-sold drug products in 
the United States and European markets are administered orally.5 Once swallowed, with an 
adequate volume of water, a tablet will leave the oral cavity and rapidly pass along the 
esophagus into the stomach, where disintegration of the tablet might occur within minutes in 
the case of immediate-release dosage forms. The released drug will then dissolve in the 
gastrointestinal fluids, and the drug solution will pass directly into the small intestine, the 
optimal site for the absorption of most drugs into the systemic circulation. Drug absorption is 
normally completed in the small intestine, although on some occasions drug enters the large 
intestine where absorption of certain drugs is possible.2  
However, some drugs may irritate the stomach or degrade at a pH between 2 or 3. It is 
advantageous to protect such drugs during passage into the small intestine. Colon delivery 
becomes increasingly important due to the increasing demand of oral administration of 
proteins and other macromolecules, such as insulin and heparin.6 In order to minimize the 
exposure to proteolytic enzymes, enteric coating and controlled release are normally used to 
keep the drugs intact before they reach the target site of absorption. 
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In addition to providing the protection to the drug before reaching the absorption site, a 
controlled delivery can also maintain a prolonged therapeutic effect at a reduced dosing 
frequency.  
A dosage form generally consists of one or more active ingredients together with a 
varying number of excipients added to facilitate the preparation and administration, promote 
the consistent release and bioavailability of the drug, and protect it from degradation.7 
According to their functions, excipients could be glidants, binders, diluents, and disintegrants. 
For example, an aminophylline table comprises aminophylline, corn starch, 
polyvinylpyrrolidone, magnesium stearate, hydrated magnesium silicate, and water.  
Hydrogels are hydrophilic polymers commonly used as sustained release agents in 
pharmaceutical formulations because of their ability to form a gel network upon swelling, 
which entraps the drug and acts as a barrier to its release to the surrounding medium. 
 
1.1. Polysaccharides as Drug Delivery Excipients 
Polysaccharides are polymeric carbohydrate structures with repeating units joined 
together by glycosidic bonds. These structures are often linear, but may contain various 
degrees of branching. Polysaccharides are the most abundant natural polymers that exist in 
algae (e.g., alginate, carrageenan), plants (e.g., starch, cellulose, pectin, guar gum), microbes 
(e.g., dextran, xanthan gum), and animals (e.g., chitosan, chondroitin). Polysaccharides are 
highly stable, non-toxic, hydrophilic, degradable, and bioadhesive (adhesion to mucus gel). 
All of these properties are highly desirable for drug excipients. The pharmaceutical 
applications of polysaccharides have drawn much interest due to their proved ability to 
control drug release. The number of available polymers has substantially increased, leading to 
a wider range of applications.  
Polysaccharides can be divided into three categories according to the functional groups 
attached to the glucose rings: anionic, cationic, and non-ionic polysaccharides. Starch and 
cellulose are non-ionic; chitosan is cationic due to the presence of –NH2 groups; pectin, 
alginate, carrageenan are anionic due to the presence of –COOH or SO3- groups. Non-ionic 
pharmaceutical polymer matrices exhibit pH-independent drug release profiles while ionic 
matrices show interesting pH-sensitive swelling behaviors, which is of great significance for 
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designing controlled release systems and cancer drug delivery due to the pH gradients in 
gastrointestinal tract from stomach to colon and across tumor cell compartments.8, 9 
 
1.1.1. Starch 
Starch is the safest carbohydrate. It consists of two types of molecules: the linear and 
helical amylose (20 – 25 wt%) and the highly branched amylopectin (75 – 80 wt%) (Figure 
1.1). Amylose has a molecular weight approximately between 40,000 and 340,000, while 
amylopectin has a much higher molecular weight which may reach 80,000,000.  
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Figure 1.1. The chemical structures of (A) amylose and (B) amylopectin. 
 
Starch is widely used as glidant, diluent, disintegrant and binder for tablets. It is 
generally recognized that drug release is strongly influenced by the starch origin and its 
degree of cross-linking in the tablet.7, 10-12 The degree of cross-linking is directly related to the 
capacity of the starch to undergo a transition from V- to B-type double helix arrangement 
upon hydration, which is very important in controlling water transport and drug release 
rate.13, 14 
The presence of –OH group at positions C2, C3, C6 of glucose allows for various 
modifications of amylose and amylopectin. Carboxymethyl starch has been studied for its 
gastroprotection capacity as it has a pKa around 4.2. In acidic medium, carboxylic groups are 
protonated, giving a compact shape of the tablets.15, 16 In the absence of cross-linking, drug 
release from monolithic tablets made of carboxymethyl starch is controlled by a combination 
of tablet erosion and diffusion of the drug from the swollen matrix.15, 17, 18 
Both starch and sodium carboxymethyl starch have been approved by US Food and Drug 
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Administration (USFDA) for use as inactive ingredients in oral tablets and capsules.19  
  
1.1.2. Cellulose 
Cellulose is the skeletal substance of all vegetable tissues and the most abundant polymer 
on earth. It consists of a linear chain of several hundred to over ten thousand D-glucose units 
which are β-1,4 linked (Figure 1.2 A). Every other glucose in cellulose is flipped over due to 
the β-1,4 linkages, which promotes intrachain and interchain hydrogen bonds, as well as van 
der Waals interactions. These interactions make cellulose linear and highly crystalline.7 
Cellulose is insoluble in water and in most of the common solvents; the poor solubility is 
attributed primarily to the strong hydrogen bonding. However, the solubility may be enhanced 
by substitutions and is highly dependent on the degree of substitution. The cellulose 
derivatives are mainly obtained by esterifications and etherifications at the hydroxyl groups 
of cellulose, yielding products such as sodium carboxymethyl cellulose and methyl cellulose, 
etc. Hydroxypropyl methylcellulose (HPMC) (Figure 1.2 B) is one of the most commonly 
used polymers to retard the release of water-soluble drugs.20-23 Since the hydroxypropyl group 
is hydrophilic and methoxyl group is hydrophobic, the ratio of hydroxypropyl to methoxyl 
content affects the extent of polymer interaction with water. This property will in turn 
influence water mobility in a hydrated gel layer and drug release.20, 24, 25 The viscosity of 
HPMC plays an important role regulating tablet swelling and drug release. Higher viscosity 
grades of HPMC normally lead to slower swelling and drug release due to the greater effect 
of chain entanglement associated with higher molecular weights.26 
Many cellulose derivatives have been approved by USFDA for use as inactive 
ingredients in oral tablets and capsules. They include carboxymethyl cellulose, cellulose 
acetate, ethylcellulose, methyl hydroxyethyl cellulose, and HPMC, etc.19 
 
O
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O
OHO
OH
OH
O
O
HO
OH
OH
O
O
R2O
OR3
O
OR1
R1, R2, R3 = H, CH3, or CH2CH(OH)CH3
n
(A) (B)  
Figure 1.2. The chemical structures of (A) cellulose and (B) hydroxypropyl methyl cellulose 
(HPMC).  
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1.1.3. Chitosan 
Chitosan has attracted research attention for decades.27, 28 Chitosan is produced 
commercially by deacetylation of chitin, which is the structural element in the exoskeleton of 
crustaceans (crabs, shrimps, etc.). Chitosan is a linear cationic polysaccharide composed of 
randomly distributed β-1,4 linked D-glucosamine (deacetylated unit) and N-acetyl-D-
glucosamine (Figure 1.3). Very interestingly, chitosan can prolong residence time in 
gastrointestinal tract through mucoadhesion, and enhance absorption by increasing 
permeability, which are major factors contributing to its widespread evaluation as a 
component of oral dosage forms. The pKa value of chitosan is around 6.3. Chitosan is thus 
insoluble in water at neutral pH but soluble under slightly acidic conditions due to the 
protonation of the amine groups.27 The pH sensitivity makes chitosan a unique polymer for 
oral drug delivery applications. However, the physicochemical properties of chitosan vary by 
its molecular weight, degree of deacetylation, the salt form, and charge density.  
 
O
HO
R
Ο
OH
n
R = NH2 or NHCOCH3
O
HO
R
Ο
OH
n
R = NHCOCH3
(A) (B)  
Figure 1.3. The chemical structures of (A) chitin and (B) chitosan. 
 
Chitosan's amine groups and hydroxyl groups allow chemical derivatization by which the 
properties of this polymer can be modulated and adjusted to the intended application. This 
leads to a large variety of chitosan derivatives with different physical and biological 
properties, such as improved solubility and permeation enhancement. 
To date, neither chitosan nor its derivatives has been approved by USFDA for use as 
inactive ingredients in oral drug dosage forms due to safety and tolerability concerns. 
Chitosan might cause mineral and vitamin depletion in the GIT.  
To summarize, polysaccharides are biocompatible, biodegradable, mucoadhesive, and 
chemically versatile. The physicochemical properties and the drug delivery performances of 
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polysaccharides are influenced by factors such as ratio of components (amylose/amylopection 
ratio for starch, deacetylation degree of chitosan), molecular weight and viscosity, 
substitution degree, interaction between drug and matrix, cross-linking degree, and charge 
density, etc. The desirable pharmacokinetics may be tailored by functionalizations of the 
suitable polysaccharides. In the expanding field of controlled drug delivery, pharmaceutical 
polymers based on polysaccharides are playing an increasingly important role.  
Other polysaccharides of pharmaceutical interest are presented in Appendix I for 
reference.  
 
1.2. Drug Release Kinetics 
Nearly all of the oral extended-release dosage forms fall into one of the following two 
technologies: matrix (monolithic) systems which consist of a rate-controlling polymer matrix 
through which the drug is dissolved or dispersed, and reservoir (coated) systems where drug-
containing core is enclosed within a polymer coating.20 A matrix tablet is the simplest and the 
most cost-effective method to fabricate an extended-release dosage form. 
The mechanism of drug release from hydrophilic matrix tablets is based on diffusion of 
the drug and erosion of the outer hydrated polymer on the surface of the matrix.20 Typically, 
when the matrix tablet is exposed to gastrointestinal fluids, the surface of the tablet is wetted 
and a gel layer formed around the matrix, which acts as a diffusing barrier to drug release. 
During the process, the polymer matrix undergoes a transition from the glassy to rubbery 
state. This leads to the relaxation of the matrix which also contributes to the mechanism of 
drug release. In the case of a highly soluble drug, an initial burst release occurs due to the 
presence of the drug on the surface of the matrix tablet. The gel layer (rubbery state) grows 
with time as more water permeates into the matrix, along with the shrinkage of the glassy 
core.  
If the matrix is not cross-linked, as the outer layer becomes fully hydrated, the polymer 
chains become completely relaxed and can no longer maintain the integrity of the gel layer, 
thereby leading to disentanglement and erosion of the surface of the matrix. Water continues 
to penetrate towards the core of the tablet through the gel layer until it has been completely 
eroded.20  
Only slight erosion occurs if the matrix is cross-linked. The tablet reaches its maximum 
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swelling after immersion in the media for a few hours, well before the whole tablet becomes 
fully hydrated. But the diffusing rates of the water towards the core and the drug out of the 
gel still increase until the processes reach equilibrium. The duration varies remarkably with 
the polymer matrix from 2-3 hours to days. 
Drug solubility is an important factor determining the mechanism of drug release from 
hydrophilic matrix. Soluble drugs can be released by a combination of diffusion and erosion 
mechanisms whereas erosion is the predominant mechanism for insoluble drugs.20, 29 The 
insoluble drug may dissolve slowly and have slow diffusion through the gel layer of the 
hydrophilic matrix. Therefore, the drug is released through the erosion of the surface of the 
hydrated matrix. For drugs with very high solubility, the drug dissolves within the gel layer 
and diffuses out into the media. Take HPMC tablets as an example, the drug release rate is 
controlled mainly by diffusion and erosion (or polymer dissolution) for soluble and insoluble 
drug, respectively.26  
The diffusion in polymers can be divided into three categories depending on the rates of 
diffusion and relaxation. If the rate of diffusion is much lower than that of relaxation, the 
diffusion is called Case I or Fickian diffusion. In Case II, diffusion is much more rapid than 
the relaxation processes. Non-Fickian or anomalous diffusion occurs when the diffusion and 
relaxation rates are comparable.30 Glassy polymers generally exhibit non-Fickian behavior 
while the diffusion in rubber polymers is Fickian because rubber polymers respond very 
rapidly to changes.30  
A large number of mathematical models have been developed to describe drug release 
profiles from matrix systems.20, 22, 31-33 The simplest yet most widely used model is the one 
derived by Korsmeyer et al.34: 
/ ntM M k t∞ = ⋅                                                           (1.1) 
where Mt / M∞ is the fraction of drug release, k is the diffusion rate constant, t is the release 
time and n is the exponent indicative of the mechanism of drug release. If a tablet is 
analogous to a slab, the exponent n is 1.0 or 0.5, the drug release mechanism follows zero-
order release kinetics (also termed as Case II transport) or Fickian diffusion (Case I 
transport), respectively.35 Values of n between 0.5 and 1 indicate the contribution of both the 
diffusion process as well as polymer relaxation in controlling the release kinetics (non-
Fickian, anomalous or first-order release). For cylindrical tablets, these values are 0.45, 0.45 
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< n < 0.89 and 0.89 for Fickian, anomalous or Case II transport, respectively.22 Drug release 
profiles from HPMC hydrophilic matrices are generally first-order for highly soluble drugs or 
zero-order for practically insoluble drugs, with the release exponent n ranging from 0.5 to 
0.8.20 The anomalous release is owing to the contribution of a mechanism other than diffusion 
of drug transport.36  
More complex mechanistic theories that consider diffusion, swelling and dissolution 
processes simultaneously have been developed.22 The choice of the appropriate mathematical 
model strongly depends on the desired predictive ability.  
 
1.3. The Characterization of Polymer Matrices 
The polymer matrix and the resultant tablets have been studied by various techniques, 
such as optical imaging,12, 26, 37-39 mechanical method,40 Fourier transform infrared 
spectroscopy (FT-IR),11, 41 X-ray diffraction,11, 41 X-ray computed microtomography (CMT),42 
scanning electron microscopy (SEM),40, 42 cross-polarization magic angle spinning (CP-
MAS) nuclear magnetic resonance (NMR) spectroscopy,14, 43, 44 and NMR imaging.45-50 
Gravimetric experiments and dissolution tests are also widely used in the aim to study the 
drug release mechanism.  
 
1.3.1. XRD and FT-IR Studies 
The drug release rate of the tablets based on cross-linked high amylose starch (CHAS) 
was studied as a function of cross-linking degree, which showed that sustained release up to 
20 h was achieved at a low cross-linking degree of 6% (the weight ratio of epichlorohydrin to 
high amylose starch). The CHAS tablets of higher cross-linking degree up to 20% showed a 
sharp decrease in the release time. Typically, a tetrafunctional polymer network would be 
created by increasing the degree of cross-linking, leading to a reduced swelling capacity. 
However, CHAS yielded a nonlinear response for swelling capacity and drug release.51 X-ray 
diffraction studies suggested that the increase in cross-linking degree induces a transition of 
amylose from B-type (double helix) to a predominant V-type (single helix) and a loss in 
crystallinity. A high cross-linking degree also limited chain flexibility. Another consequence 
was that fewer chains were stabilized by interchain hydrogen-bonding and thus more 
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hydroxyl groups were available for dynamic exchange with free water, which facilitates 
hydration of the CHAS power, as reflected by the intensity of FT-IR water deformation 
vibration mode.41 The conformation studies suggested that an optimized 
crystalline/amorphous ratio is responsible for tablet integrity during swelling, water 
penetration, and drug release of the CHAS-based monolithic dosage forms.11  
 
1.3.2. SEM and CMT Studies 
The SEM and CMT experiments demonstrated the skin-core structure of the CHAS 
tablets as a result of interaction with water and reorganization.42 The core is surrounded by 
the skin consisting of two concentric layers, an inner porous membrane and an outer very 
dense membrane, which acts as pseudo-crosslinks and retain the integrity of the tablets.  
The gravimetric method can be used to record water uptake of drug tablets. At 
appropriate time intervals, each tablet is removed from water and weighed. The water uptake 
data can be used to determine water diffusion mechanism. For example, the dynamic swelling 
and equilibrium swelling of poly(2-hydroxyethyl methacrylate-co-methacrylic acid) 
(poly(HEMA-co-MAA)) in buffer of different pH values were studied gravimetrically.52 The 
mechanism of water diffusion in the gel became more anomalous as the pH of the swelling 
medium increased and as the ionic strength decreased at a constant pH ≥ pKa. The mechanism 
of water diffusion was Fickian and independent of ionic strength at a pH lower than the pKa. 
The anionic polymeric networks ionized as the pH of the medium rose above the pKa of that 
ionizable moiety. Increasing ionization at higher pH might affect the relative magnitude of 
diffusion and relaxation times. The reason is that the electrostatic repulsion between adjacent 
ionized carboxylate groups led to chain expansion, which in turn affected polymer chain 
relaxation. Despite the easy access, the gravimetric method has a disadvantage that the tablet 
transfer process and the ex-situ method would inevitably affect the swelling process and alter 
the fragile outer region of the gel, to the detriment of accuracy. 
 
1.3.3. Dissolution Studies 
Dissolution test is the only way to measure the rate of in vitro drug release as a function 
of time. Dissolution tests are commonly conducted according to the procedure now rigorously 
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and comprehensively defined in US Pharmacopeia. The objective of the dissolution test is to 
establish dissolution mechanism. In general, analytical methods used for quantifying drug 
release in dissolution tests can be classified into four categories: spectrophotometric, 
chromatographic, mass spectrometric, and potentiometric. Direct UV-vis spectrophotometric 
determination is most widely used for drug containing chromophores. The drug release 
profile is then used to determine whether the drug release is controlled by diffusion or by 
polymer relaxation mechanism.  
A dissolution study was done to follow the behavior of CHAS derivatized with cationic 
(carboxymethyl), anionic (aminoalkyl) groups and less polar group (acetate) to study their 
release control properties and interactions with charged drugs (acetylsalicylic acid and 
metformin) and an uncharged drug (acetaminophen).53 Ionic interactions retarded drug release 
effectively, the effect being more significant at high drug loading in the case of drugs of high 
solubility (such as metformin). 
 
1.3.4. Optical Imaging 
Optical imaging has been used to track the penetration of water into the tablets.12, 26, 37-39 
This method offers ease of manipulation with relatively low instrument cost. The gel layer 
normally appears as a bright ring and the dry core as a dark part due to the scattering of light 
by the hydrated polymer.37 In digital image processing, the image is converted into a discrete 
number of points called pixels, which are assigned a numeric location and grey level value. 
The intensity of the signal was related to the water content in the tablets, the method is 
therefore not only used to monitor the tablet swelling, but also to characterize the moving 
front and the solvent concentration gradient. Optical imaging also demonstrated that the 
equilibrium swelling state was attained much after the solvent penetration fronts had met.12 
On the basis of the empirical relationship between scattered light intensity and HPMC 
concentration, the apparent gel region of a swelling HPMC tablet can be defined with respect 
to polymer concentration. The polymer concentration within the gel layer of HPMC tablets is 
around 5-50%.37 As a matter of fact, the solvent penetration front goes slightly deeper than 
the apparent gel front. A very small portion of the gel region of higher polymer concentration 
is beyond the detection limit of optical imaging due to the opacity.  
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1.3.5. NMR Imaging Studies 
NMR imaging (NMRI) has been used to study the matrix systems for more than a decade 
as NMRI can provide cross-sectional images from inside solid materials.24, 39, 46-50, 54-63 
Contrary to this, optical imaging can only observe the surface and the averaged diffraction 
signal of a tablet. NMRI uses magnetic field gradients to encode the NMR signal with spatial 
information. The amplitude of the signal indicates the water concentration at a particular 
position within the sample. The noninvasive and nondestructive nature of NMRI is especially 
advantageous for tracking the water penetration and the swelling of the matrix of the tablets 
in terms of both the development of the gel layer and the dimensional change of the core. 
Quantitative information can be obtained regarding the kinetics of the diffusion process and 
the polymer or drug concentration gradient upon hydration exclusively by NMRI rather than 
optical imaging.12 A number of investigations47, 49, 55, 56, 64, 65 aimed at characterizing the 
formation of the gel layer and determining how its properties influence drug release. 
Normally the images of the dimensional changes in the gel layer and the core are monitored 
and solvent concentration profiles (proton density profiles) are extracted from the images. 
NMRI can also be used to monitor the distribution of drug inside the tablets. For example, 19F 
NMRI was chosen to measure triflupromazine–HCl and 5-fluorouracil concentration in 
HPMC-based tablets.29  
Diffusion-weighted NMR imaging experiments are essential to studying the mobility of 
water inside the gel layer and determine the spatial distribution of self-diffusion coefficient of 
water. Such kind of studies showed that there was a water mobility gradient across the gel 
layer of HPMC and poly(vinyl alcohol) (PVA) matrices and the limited mobility of polymer 
chains near the glassy region hindered solvent transport.24 From the outer gel to the glassy 
core, the self-diffusion coefficient of water decreases from that of free water (2×10-9 m2/s at 
25oC) to zero.24  
 
1.3.6. Relaxation Time Studies 
T2 (transverse relaxation time) measurement of tablets is an interesting method to deduce 
the polymer concentration of hydrated layer of the swollen tablets.45 Firstly, the dependence 
of the 1H T2 values on the HPMC weight fraction was obtained by measuring the relaxation 
times of equilibrated mixtures of HPMC solution of known concentrations. HPMC weight 
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percentages were then calculated from T2 values with the determined calibration. At the same 
time, the percentages of the water bound to polymer and the free water were obtained.  
 
1.4. Diffusion in Polymer-Water-Diffusant Systems 
The diffusion of small molecules to macromolecules in polymer solutions and gels has 
attracted increasing research interest in the past decade. A particular important application 
involves the hydrogels as controlled release carriers of drugs. The effects of polymer 
concentration, size, and shape of the diffusant, temperature, and specific interactions within 
the polymer matrix are important in determining the diffusion properties in a polymer system. 
Our group has extensively studied the self-diffusion of small and large molecules in polymer-
water-diffusant systems by pulsed-gradient spin-echo (PGSE) NMR spectroscopy.66-73  
The diffusants having been studied included water, methanol, tert-butanol, formamide, 
acetic acid, trimethylamine, tetramethylammonium cation, oligo- and poly(ethylene glycol) of 
increasing molecular weight from 62 to 10,000,66-69 a series of end-capped ethylene glycol 
and oligo(ethylene glycol),70 poly(propyleneimine) dendrimers (generations 2, 4, and 5),71 
hyperbranched polyglycidols,72 and carboxylated dendrimers.73  
The matrices are mainly poly(vinyl alcohol) (PVA).66-73 Besides, hydroxypropyl methyl 
cellulose (HPMC),69 poly(N,N-diethylacrylamide) (PNNDEA),69 poly(N-
isopropylacrylamide) (PNIPA),69 and poly(allyl amine) (PAAm)73 were also used to study the 
effects of different matrices and ionic interactions between the diffusants and the polymer 
matrices.  
 
1.4.1. Molecular Size of the Diffusant 
It was found that at a given polymer concentration the size of the diffusant has the most 
significant effect on its diffusion in the absence of strong interactions between the diffusants 
and the polymer network.66-72 
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1.4.2. Concentration of the Polymer 
The self-diffusion coefficient of diffusants ranging from small molecules to 
macromolecules in PVA solutions and gels decreased with increasing PVA concentration 
(from 0 to 0.38 g/mL).66-73  
 
1.4.3. Molecular Weight and Hydrolysis Degree of the Polymer  
The diffusion of both small molecules and linear poly(ethylene glycol)s (PEGs) did not 
vary significantly with the molecular weight (50,000 and 115,000) of the PVA matrix, and 
only a small variation was observed with the degree of hydrolysis of the PVA (87% and 
99%).66  
 
1.4.4. Geometry of the Diffusant 
The molecular geometry of the diffusant plays an important role in the diffusion process, 
as reflected by a study of a series of end-capped ethylene glycol and oligo(ethylene glycol)s 
in PVA aqueous solutions and gels.70 The end groups included both flexible groups (methyl, 
ethyl, hexyl) and rigid groups (tert-butyl and aromatic groups). The results showed that the 
methyl groups reduced or prevented the binding of ethylene glycol to PVA.70 Diffusants with 
a bulkier end group (such as tert-butyl group) diffused less rapidly than those with a smaller 
linear end group even though the molecular weights of the molecular are comparable.70  
The dendritic polymers, poly(propyleneimine) dendrimers with hydrophilic triethylenoxy 
methyl ether terminal groups diffused faster in PVA aqueous solutions and gels than the linear 
PEGs when the molecular weights were similar.71 Hyperbranched polyglycidols of molecular 
weights from 300 to 2000 were also studied.72 For diffusants of similar molecular weight and 
without specific interactions, the activation energy increased from the dendrimers to 
hyperbranched polymers and then to linear polymers.72  
 
1.4.5. Effect of Temperature 
The studies on the effect of temperature on the diffusion of oligo- and poly(ethylene 
glycol)s showed that the self-diffusion coefficients increased with increasing temperature.67, 
68, 71, 73 
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1.4.6. Interaction Between the Diffusants and the Polymers 
The study of the diffusion of small molecules with different functional groups (alcohol, 
amine, ammonium salt, amide, and acid) in PVA solutions and gels showed that the 
interactions had little impact on the diffusion behaviour because the diffusion was primarily 
influenced by the size of the diffusant.66  
The ionic interaction between the carboxylated dendritic diffusants and the cationic 
poly(allyl amine) network significantly reduced the diffusion rate of the diffusant. The self-
diffusion coefficients were an order of magnitude lower than those in PVA and the values 
were more widely distributed.73  
 
1.4.7. Various Polymer Matrices 
The effect of the polymer matrices on the self-diffusion of PEG with a molecular weight 
600 was studied for different ternary polymer-water-PEG systems (PVA, HPMC, PNNDEA, 
and PNIPA).69 The diffusion in hydrophilic polymers was mostly affected by formation of the 
hydrogen bonds between the solute and the polymer matrix.  
Several pertinent physical models of diffusion were evaluated and the physical 
significance of the parameters were analyzed as well.67 These models were based on the 
obstruction effect, the free volume effect, or hydrodynamic interactions. The difficulties in 
their applications include failure to describe large probes, lack of knowledge of some 
parameters that are not readily available, and lack of physical significance of the 
parameters.67-69 Our group proposed a model suitable for both small and large diffusants in 
dilute and concentrated polymer systems.74 This model has been validated by a number of 
diffusants in the polymer-water-diffusant ternary systems, including oligo- and poly(ethylene 
glycol)s,67, 68, 70 dendrimers,71, 73 hyperbranched polyglycidols72 in PVA, water and PEG69 in 
PVA, HPMC, PNNDEA, and PNIPA. In all the cases, the model successfully described the 
effects of polymer concentration, temperature, and molecular size of the diffusants. 
 
1.5. Water Diffusion in CHAS Tablets 
The CHAS powder has been prepared according to US patents.75, 76 The starch of a high 
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content of amylose was chosen because it yielded a stronger gel.51 Firstly, high-amylose 
starch was activated by heating in sodium hydroxide solution. Phosphorous oxychloride was 
used as the cross-linking agent along with propylene oxide added to further functionalize 
amylose and amylopectin molecules. Covalent cross-links and hydroxypropyl side chains of 
the final product allow greater stability by hindering retrogradation over time.51 
Retrogradation of starch is used to define the changes from amorphous state to a more 
ordered or crystalline state.  
CHAS attracted attention due to its sustained drug release property as an excipient of oral 
drug dosage form. A membrane at the outer layer of CHAS tablets quickly formed upon 
hydration and the tablets could maintain the integrity in water for days. The absence of 
erosion and limited swelling allow for further explorations of the applications in drug 
delivery.13  
CHAS tablets have been extensively studied by NMRI and a few other polymer 
characterization techniques by our group.46-50, 55 The result obtained were summarized 
hereafter. 
 
1.5.1. Swelling of CHAS Tablets   
Similar to other tablets, when a CHAS tablet is immersed into water, water penetrates 
into the hydrophilic polymer matrix easily to form a hydrogel, leading to a steep water 
gradient. The formation of the membrane which acts as a barrier opposing water and drug 
transport was well characterized by NMRI.42, 49 The glassy-rubbery transition is based on the 
lowering of the glass-transition temperature (Tg) of the polymer, which is controlled by the 
water concentration and depends on temperature and thermodynamic interactions of the 
polymer-water system.36 The swelling of the CHAS tablets approaches its maximum at 
around 10 h at 37 oC but 60% of swelling can be achieved within the first 4 h.48  
The swelling is anisotropic with the axial swelling being much more significant than the 
radial swelling for all the tablets of different sizes and within the temperature range from 25 
to 60oC.46-48 The more pronounced axial swelling was related to the relief of the stresses 
induced during compaction of the matrix tablets.77 However, the gel layer along both 
directions are similar in thickness.39 
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1.5.2. Effect of Temperature 
Four temperatures (25, 37, 45, and 60 oC) were employed to study the water diffusion 
and the swelling of the CHAS tablets.46, 48 The tablets have a faster swelling with increasing 
temperature up to 60 oC. The diffusion process is Fickian between 25 and 45 oC and Case II at 
60 oC. The difference is caused by the different degrees of the transformation from V-type 
single helix polymorph to B-type double helices during water uptake.47, 48 The double helical 
conformation acts as physical cross-links which in turn limits the swelling and thus is 
essential for sustained drug release, which is verified by CP-MAS 13C NMR spectroscopy. 
The details of the transformation include the following steps with water penetrating into a 
tablet to act as a plasticizing agent. This plasticizing effect increases intermolecular space and 
thus allows greater mobility to starch molecules which rapidly start reorganizing into the 
thermodynamically most stable conformations: B-type double helices.51  
 
1.5.3. Effect of the Tablet Size 
The water uptake and the tablet swelling strongly depend on the size of the tablets.47 The 
swelling rate is faster for the small tablet along both swelling directions due to its larger 
surface/volume ratio. In both cases, the decrease of the dry thickness is more rapid than that 
of the dry diameter with immersion time.  
 
1.5.4. Effect of Drug Loading 
The drug loading effect has been studied by comparing tablets loaded with 10 wt% 
soluble drugs (ciprofloxacin and acetaminophen) and tablets containing exclusively polymer 
matrix.49 The extent of the swelling of the tablets was not noticeably influenced by a 10 wt% 
drug-loading, since the presence of drugs at this content did not interfere with the formation 
of double helices which limited the overall swelling of the CHAS tablets.49 However, the 
presence of drug molecules caused a faster water uptake, as reflected by the higher diffusion 
coefficients of water.  
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1.6. Objectives of This Study 
The objective of the study is to elucidate the effect of architecture of polymers, the level 
of drug loading, and the pH value and ionic strength of the environment on the diffusion of 
the diffusant and the swelling of the polymer matrices. A justification for these choices 
follows. 
Every natural or synthetic polymer falls into one of the following categorized 
architectures: linear, graft, branched, cross-linked, star-shaped, and dendritic. The effect of 
shape of the diffusants has been preliminarily investigated by comparing the diffusion of 
linear, dendritic, and hyperbranched polymers in polymer aqueous solutions and gels.71, 72 As 
a series of star-shaped polymers with four arms have been successfully synthesized in our 
group, a comparison among the polymers of different architectures becomes highly desirable.  
Hydrophilic drugs have been believed to trigger water uptake and water diffusion into the 
polymer matrix, and thus it is challenging to yield a sustained release when the level of drug 
loading is high. The CHAS tablets loaded with only 10 wt% of drug have been studied up to 
now. It is important to measure the rate of water diffusion in the tablets with different drug 
loading levels and to correlate it with the swelling of the tablets and the rate of drug 
dissolution.  
In the past, all the NMR Imaging studies of the CHAS tablets used only water as the 
medium. To study the swelling of the tablets and the solvent uptake in the physiological 
environment (for example, the media simulating the stomach and the small intestine fluids) is 
of significant importance. To understand the effect of pH on the drug release from a certain 
matrix is also highly desirable due to the different pH values in human’s gastrointestinal tract. 
The pH value and ionic strength are expected to significantly affect the swelling of the 
polymer matrices containing ionic groups. A chitosan-based polyelectrolyte complex is an 
interesting material which shows pH-dependent association and dissociation among the ionic 
groups attached to the polymer chains. It should be compared with CHAS.  
 
1.7. Scope of This Study 
This thesis comprises of a series of studies leading to the development of a relationship 
between drug release kinetics and physicochemical properties of polymers such as the 
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diffusion coefficients of the polymer and water, liquid uptake, and kinetics of swelling of the 
matrices. 
Chapter 2 focuses on the diffusion of a star polymer in aqueous solution and PVA gel 
studied by PGSE NMR spectroscopy. An amphiphilic star polymer is compared with linear 
polymers and dendrimers.  
Chapter 3 presents the effect of drug loading on water uptake kinetics, swelling, drug 
release of CHAS tablets. The effect is studied by NMR imaging, drug dissolution experiments 
complementary to a quantitative measurement of diffusion coefficients in the hydrated tablets 
with acetaminophen loading up to 40 wt%.  
Chapter 4 describes the effect of pH and ionic strength of the external media on the 
swelling of tablets made of a polyelectrolyte complex. The complex is formed between 
chitosan and sodium carboxymethyl starch (CMS).  
The thesis concludes with a summary and suggestions for future work. Studies on the 
effect of polymer architecture, drug loading, and various media would be valuable for the 
development and optimization of biopolymer systems for drug delivery. 
 
1.8. References 
1. Jones, D., Pharmaceutical Applications of Polymers for Drug Delivery. Rapra 
Technology Limited: Shropshire, UK, 2004; Vol. 15. 
2. Kendall, R. A.; Basit, A. W., The Role of Polymers in Solid Oral Dosage Forms. In 
Polymer in Drug Delivery, Uchegbu, I.; Schatzlein, A., Eds. CRC Press: Boca Raton, 2006. 
3. Alexander, C. Expert Opin. Emerging Drugs 2001, 6, 345-363. 
4. Chaubal, M. V., Polymeric Excipients for Controlled Release Applications. In Excipient 
Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems, Katdare, A.; 
Chaubal, M. V., Eds. Informa Healthcare USA, Inc. : New York, 2006. 
5. Abrahamsson, B.; Lennernäs, H., Application of the Biopharmaceutic Classification 
System Now and in the Future. In Drug Bioavailability: Estimation of Solubility, 
Permeability, Absorption and Bioavailability, Waterbeemd, H. v. d.; Lennernäs, H.; 
Artursson, P., Eds. Wiley-VCH: Weinheim, 2003. 
6. Goldberg, M.; Gomez-Orellana, I. Nat. Rev. Drug Discov. 2003, 2, 289-295. 
19 
 
7. Klein, S., Polysaccharides in Oral Drug Delivery –Recent Applications and Future 
Perspectives In Polysaccharide Materials: Performance by Design, Edgar, K. J.; Heinze, T.; 
Buchanan, C. M., Eds. ACS: 2009. 
8. Na, K.; Bae, Y. H., pH-Sensitive Polymers for Drug Delivery  In Polymeric Drug 
Delivery Systems, Kwon, G. S., Ed. Taylor & Francis Group: Boca Raton, FL, 2005. 
9. Shen, Y.; Tang, H.; Radosz, M.; Kirk, E. V.; Murdoch, W. J., pH-Responsive 
Nanoparticles for Cancer Drug Delivery. In Drug Delivery Systems, Jain, K. K., Ed. Humana 
Press: Totowa, NJ, 2008. 
10. Onofre, F.; Wang, Y.-J.; Mauromoustakos, A. Carbohydr. Polym. 2009, 76, 541-547  
11. Ispas-Szabo, P.; Ravenelle, F.; Hassan, I.; Preda, M.; Mateescu, M. A. Carbohydr. Res. 
2000, 323, 163-175. 
12. Moussa, I. S.; Cartilier, L. H. J. Control. Release 1996, 42, 47-55. 
13. Lenaerts, V.; Moussa, I.; Dumoulin, Y.; Mebsout, F.; Chouinard, F.; Szabo, P.; 
Mateescu, M. A.; Cartilier, L.; Marchessault, R. J. Control. Release 1998, 53, 225-234. 
14. Thérien-Aubin, H.; Janvier, F.; Baille, W. E.; Zhu, X. X.; Marchessault, R. H. 
Carbohydr. Res. 2007, 342, 1525-1529. 
15. Massicotte, L. P.; Baille, W. E.; Mateescu, M. A. Int. J. Pharm. 2008, 356, 212-223. 
16. Calinescu, C.; Mateescu, M. A. Eur. J. Pharm. Biopharm. 2008, 70, 582-589. 
17. Sen, G.; Pal, S. J. Appl. Polym. Sci. 2009, 114, 2798-2805. 
18. Brouillet, F.; Bataille, B.; Cartilier, L. Int. J. Pharm. 2008, 356, 52-60. 
19. Inactive ingredients database. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm 
(April 3, 2010),  
20. Tiwari, S. B.; Rajabi-Siahboomi, A. R., Extended-Release Oral Drug Delivery 
Technologies: Monolithic Matrix Systems. In Drug Delivery Systems, Jain, K. K., Ed. 
Humana Press: Totowa, NJ 2008. 
21. Cao, Q. R.; Choi, Y. W.; Cui, J. H.; Lee, B. J. J. Control. Release 2005, 108, 351-361. 
22. Siepmann, J.; Peppas, N. A. Adv. Drug Deliver. Rev. 2001, 48, 139–157. 
23. Rowe, R. C.; Sheskey, P. J.; Quinn, M. E., Handbook of Pharmaceutical Excipients. 6th 
ed.; Pharmaceutical Press: London, 2009. 
24. Rajabi-Siahboomi, A. R.; Bowtell, R. W.; Mansfield, P.; Davies, M. C.; Melia, C. D. 
Pharm. Res. 1996, 13, 376-380. 
20 
 
25. McCrystal, C. B.; Ford, J. L.; Rajabi-Siahboomi, A. R. J. Pharm. Sci. 1999, 88, 797-801. 
26. Pham, A. T.; Lee, P. I. Pharm. Res. 1994, 11, 1379-1384. 
27. Kumar, M. N. V. R.; Muzzarelli, R. A. A.; Muzzarelli, C.; Sashiwa, H.; Domb, A. J. 
Chem. Rev. 2004, 104, 6017-6084. 
28. Park, J. H.; Saravanakumar, G.; Kim, K.; Kwon, I. C. Adv. Drug Deliver. Rev. 2010, 62, 
28-41. 
29. Fyfe, C. A.; Blazek-Welsh, A. I. J. Control. Release 2000, 68, 313-333. 
30. Crank, J., The Mathematics of Diffusion. 2nd ed.; Oxford University Press: Oxford, 
1975. 
31. Narasimhan, B. Adv. Drug Deliver. Rev. 2001, 48, 195-210. 
32. Siepmann, J.; Göpferich, A. Adv. Drug Deliver. Rev. 2001, 48, 229-247. 
33. Parker, R. S.; Doyle III, F. J. Adv. Drug Deliver. Rev. 2001, 48, 211-228. 
34. Korsmeyer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A. J. Pharm. Sci. 1983, 
72, 1189–1191. 
35. Bajwa, G. S.; Hoebler, K.; Sammon, C.; Timmins, P.; Melia, C. D. J. Pharm. Sci. 2006, 
95, 2145–2157. 
36. Colombo, P.; Bettini, R.; Santi, P.; Peppas, N. A. Pharm. Sci. Technol. To. 2000, 3, 198-
204. 
37. Gao, P.; Meury, R. H. J. Pharm. Sci. 1996, 85, 725-731. 
38. Bussemer, T.; Peppas, N. A.; Bodmeier, R. Eur. J. Pharm. Biopharm. 2003, 56, 261-270. 
39. Moussa, I. S.; Lenaerts, V.; Cartilier, L. H. J. Control. Release 1998, 52, 63–70. 
40. Ravenelle, F.; Marchessault, R. H.; Legare, A.; Buschmann, M. D. Carbohydr. Polym. 
2002, 47, 259-266. 
41. Dumoulin, Y.; Alex, S.; Szabo, P.; Cartilier, L.; Mateescu, M. A. Carbohydr. Polym. 
1998, 37, 361-370. 
42. Chauve, G.; Ravenelle, F.; Marchessault, R. H. Carbohydrate Polymers 2007, 70, 61-67. 
43. LeBail, P.; Morin, F. G.; Marchessault, R. H. Int. J. Biol. Macromol. 1999, 26, 193-200. 
44. Shiftan, D.; Ravenelle, F.; Mateescu, M. A.; Marchessault, R. H. Starch-Starke 2000, 52, 
186-195. 
45. Fyfe, C. A.; Blazek, A. I. Macromolecules 1997, 30, 6230-6237. 
21 
 
46. Baille, W. E.; Malveau, C.; Zhu, X. X.; Marchessault, R. H. Biomacromolecules 2002, 3, 
214-218. 
47. Malveau, C.; Baille, W. E.; Zhu, X. X.; Marchessault, R. H. Biomacromolecules 2002, 3, 
1249-1254. 
48. Thérien-Aubin, H.; Baille, W. E.; Zhu, X. X.; Marchessault, R. H. Biomacromolecules 
2005, 6, 3367-3372. 
49. Thérien-Aubin, H.; Zhu, X. X.; Ravenelle, F.; Marchessault, R. H. Biomacromolecules 
2008, 9, 1248-1254. 
50. Thérien-Aubin, H.; Zhu, X. X. Carbohydr. Polym. 2009, 75, 369-379. 
51. Ravenelle, F.; Rahmouni, M., Contramid: High-Amylose Starch for Controlled Drug 
Release. In Polysaccharides for Drug Delivery and Pharmaceutical Applications, 
Marchessault, R. H.; Ravenelle, F.; Zhu, X. X., Eds. American Chemical Society: 
Washington, DC, 2006; pp 79-104. 
52. Khare, A. R.; Peppas, N. A. Biomaterials 1995, 16, 559-567. 
53. Mulhbacher, J.; Ispas-Szabo, P.; Lenaerts, V.; Mateescu, M. A. J. Control. Release 2001, 
76, 51-58. 
54. Dahlberg, C.; Fureby, A.; Schuleit, M.; Dvinskikh, S. V.; Furo, I. J. Control. Release 
2007, 122, 199-205. 
55. Thérien-Aubin, H.; Zhu, X. X., Water diffusion in drug delivery systems made of high-
amylose starch as studied by NMR imaging. In Polysaccharides For Drug Delivery And 
Pharmaceutical Applications, Marchessault, R. H.; Ravenelle, F.; Zhu, X. X., Eds. American 
Chemical Society: Washington, D. C., 2006; pp 105-120. 
56. Richardson, J. C.; Bowtell, R. W.; Mader, K.; Melia, C. D. Adv. Drug Deliv. Rev. 2005, 
57, 1191-1209. 
57. Kowalczuk, J.; Tritt-Goc, J.; Pislewski, N. Solid State Nucl. Magn. Reson. 2004, 25, 35-
41. 
58. Chowdhury, M. A.; Hill, D. J. T.; Whittaker, A. K.; Braden, M.; Patel, M. P. 
Biomacromolecules 2004, 5, 1405-1411. 
59. Chowdhury, M. A.; Hill, D. J. T.; Whittaker, A. K. Biomacromolecules 2004, 5, 971-
976. 
60. Ghi, P. Y.; Hill, D. J. T.; Whittaker, A. K. Biomacromolecules 2001, 2, 504-510. 
22 
 
61. Fahie, B. J.; Nangia, A.; Chopra, S. K.; Fyfe, C. A.; Grondey, H.; Blazek, A. J. Control. 
Release 1998, 51, 179-184. 
62. Hopkinson, I.; Jones, R. A. L.; Black, S.; Lane, D. M.; McDonald, P. J. Carbohydr. 
Polym. 1997, 34, 39-47. 
63. Rajabi-Siahboomi, A. R.; Bowtell, R. W.; Mansfield, P.; Henderson, A.; Davies, M. C.; 
Melia, C. D. J. Control. Release 1994, 31, 121-128. 
64. Baumgartner, S.; Lahajnar, G.; Sepe, A.; Kristl, J. Eur. J. Pharm. Biopharm. 2005, 59, 
299-306. 
65. Kulinowski, P.; Dorozynski, P.; Jachowicz, R.; Weglarz, W. P. J. Pharm. Biomed. 2008, 
48, 685-693. 
66. Petit, J.-M.; Zhu, X. X.; Macdonald, P. M. Macromolecules 1996, 29, 70-76. 
67. Masaro, L.; Zhu, X. X.; Macdonald, P. M. Macromolecules 1998, 31, 3880-3885. 
68. Masaro, L.; Zhu, X. X.; Macdonald, P. M. J. Polym. Sci., Part B: Polym. Phys. 1999, 37, 
2396-2403. 
69. Masaro, L.; Ousalem, M.; Baille, W. E.; Lessard, D.; Zhu, X. X. Macromolecules 1999, 
32, 4375-4382. 
70. Masaro, L.; Zhu, X. X. Macromolecules 1999, 32, 5383-5390. 
71. Baille, W. E.; Malveau, C.; Zhu, X. X.; Kim, Y. H.; Ford, W. T. Macromolecules 2003, 
36, 839-847. 
72. Baille, W. E.; Zhu, X. X.; Fomine, S. Macromolecules 2004, 37, 8569-8576. 
73. Thérien-Aubin, H.; Zhu, X. X.; Moorefield, C. N.; Kotta, K.; Newkome, G. R. 
Macromolecules 2007, 40, 3644-3649. 
74. Petit, J.-M.; Roux, B.; Zhu, X. X.; Macdonald, P. M. Macromolecules 1996, 29, 6031-
6036. 
75. Lenaerts, V.; Beck, R. H. F.; Van Bogaert, E.; Chouinard, F.; Hopcke, R.; Desevaux, C. 
Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations 
and processes for its manufacture. U.S. Patent 6,607,748, August 19, 2003. 
76. Mateescu, M. A.; Lenaerts, V.; Dumoulin, Y. Use of cross-linked amylose as a matrix 
for the slow release of biologically active compounds U. S. Patent 5,456,921, Oct.10, 1995. 
77. Papadimitriou, E.; Buckton, G.; Efentakis, M. Int. J. Pharm. 1993, 98, 57-62. 
 
* Modified from a research article published: Y. J. Wang, H. Therien-Aubin, W. E. Baille, J. T. Luo, X. X. 
Zhu, Polymer, 2010, 51, 2345-2350. 
2. Effect of Molecular Architecture on the Self-Diffusion of 
Polymers in Aqueous Systems: A Comparison of Linear, Star, 
and Dendritic Poly(ethylene glycol)s* 
 
2.1. Abstract 
Star polymers with a hydrophobic cholane core and four poly(ethylene glycol) (PEG) 
arms, CA(EGn)4, have been synthesized by anionic polymerization. Pulsed-gradient spin-echo 
NMR spectroscopy was used to study the diffusion behavior of the star polymers, ranging 
from 1000 to 10,000 g/mol, in aqueous solutions and gels of poly(vinyl alcohol) (PVA) at 
23oC. The star polymers have a lower self-diffusion coefficient than linear PEGs at equivalent 
hydrodynamic radius. In water alone, the star polymers and their linear homologues have a 
similar diffusion behavior in the dilute regime, as demonstrated by the similar concentration 
dependence of the self-diffusion coefficients. In the semidilute regime, the star polymers tend 
to aggregate due to their amphiphilic properties, resulting in lower self-diffusion coefficients 
than those of linear PEGs. 1H NMR T1 measurements at 10-70 oC revealed that the PEG arms 
of the star polymers are more mobile than the core, suggesting the star polymers in solution 
have a conformation similar to that of poly(propylene imine) dendrimers.  
 
2.2. Introduction 
The study of diffusion is of fundamental importance in describing macromolecular 
solution dynamics. The determination of diffusion coefficients of macromolecules in 
solutions or gels of polymer matrices is also important for applications such as controlled 
delivery of drugs, gel electrophoresis, permeation through membranes, plasticizers in plastic 
materials, and encapsulation of drugs and fragrances.1-4 The diffusion behavior of a variety of 
oligomers and polymers, including linear poly(ethylene glycol) (PEG),5-8 dendrimer,9, 10 
hyperbranched,11-13 and star polymers14-16 have been studied. The understanding of the 
dependence of the transport behaviors of the diffusants on their size and shape may help in 
the design of polymer systems with predictable properties.17, 18 The shape of a macromolecule 
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may have a pronounced effect on its diffusion coefficient. For example, the rodlike protein 
tropomyosin (aspect ratio R = 26) and globular protein myoglobin (aspect ratio R = 1.6) 
exhibited similar behavior in agarose gels but markedly different diffusion in carrageenan 
gel,19 since agarose gel has a mesh size about 6 times of that of carrageenan gel, in which the 
diffusion of stiff tropomyosin was hindered more significantly. In aqueous solutions of 
poly(vinyl alcohol) (PVA), a cyclic poly(ethylene oxide) (PEO) of a lower molecular weight 
(Mn = 6 000) was found to have almost the same self-diffusion coefficients as linear PEO of a 
higher molecular weight (Mn = 10 000).20 
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Figure 2.1. The chemical structure of the star polymers used in this study. They are prepared 
by anionic polymerization of ethylene oxide on a core of cholic acid.21 Four PEG chains are 
attached and the chain length n = 4, 6, 10, 17, 31, 39, and 54. 
 
Star polymers have attracted significant research interests due to their compact structures 
and unique physical properties.22-24 Pulsed-gradient spin-echo (PGSE) NMR experiments 
have revealed that the molecular mobility of star-branched polyisoprenes in C6F5Cl and CCl4 
solutions depends largely on the weight fraction of the polymer, and only weakly on the 
number of the arms.14 Similarly, no marked difference was observed between linear and 
three-armed polystyrenes and polybutadienes (Mn = 3,000 – 1,000,000) in CCl4 solution from 
dilute to semidilute regime.15 Although considerable research concerning the shape effect on 
both the static and dynamic parameters of polymer solutions has been conducted, very few 
general conclusions can be drawn. The factor of molecular shape is more difficult to address 
than the molecular size and the accumulation of results helps in the elucidation of such 
effects. We have previously compared the self-diffusion of linear PEGs and poly(propylene 
imine) dendrimers bearing triethylenoxy methyl ether as end groups (PPI(TEG)n).9 In this 
work, we used star polymers CA(EGn)4, newly made by attaching four PEG chains to a 
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cholane core (Figure 2.1) by anionic polymerization21 and studied their diffusion behaviors 
using the PGSE NMR technique. The star polymers with bile acid cores were characterized in 
a previous study.21 All three series of polymers, star polymers CA(EGn)4, linear PEGs, and 
poly(propylene imine) dendrimers, share the same repeat unit, ethylene glycol, while the 
cores of the star polymers (cholic acid) and dendrimers (poly(propylene imine)) add structural 
variants for the comparative studies. The self-diffusion coefficient measurements were 
performed in either binary solutions of the diffusants or ternary systems of PVA-water-
diffusant.  
 
2.3. Experimental 
2.3.1. Materials  
PVA (MW = 89,000 – 98,000, 99% hydrolyzed) and deuterium oxide (D2O) were 
purchased from Sigma-Aldrich (Milwaukee, WI). All chemicals were used as received. The 
star polymers (Figure 2.1) were synthesized as reported previously.21 The molecular weights 
of the star polymers measured by size exclusion chromatography (SEC), MALDI-TOF mass 
spectrometry, and NMR spectroscopy21 are listed in Table 2.1 and all results show very low 
polydispersity indices (PDI = 1.02 ~ 1.05). The molecular weight were obtained both by SEC 
coupled with a refractive index detector (SEC-RI) calibrated with linear homologues and by 
SEC with a light scattering detector (SEC-LS). Both detection methods provided similar 
results, while the absolute molecular weights measured by SEC-LS are systematically 1.1 
times of the values obtained by SEC-RI. It should be noted, however, that linear PEGs were 
used as the standards for SEC-RI. The molecular weights listed in the report are those 
obtained by SEC-RI unless otherwise specified. The refractive index increment, dn/dc, was 
measured with a series of 8 solution samples in the concentration range of 0.2 – 3.0 mg/mL 
for each polymer, using a refractive index detector from Wyatt. The molecular weights were 
determined by SEC equipped with a differential refractometer (Optilab) and a multiangle 
light scattering detector (DAWN EOS, wavelength 690 nm) in N,N-dimethylformamide 
(DMF) at a flow rate of 0.5 mL/min at 25 °C with a set of styragel columns (a TSK-gel α-M, 
particle size 13 μm, exclusion limit 1×107 Da for polystyrene in DMF, and a TSK-gel α-
3000, particle size 7 μm, exclusion limit 1×105 Da for polystyrene in DMF) (Tosoh Biosep). 
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Samples were filtered through 0.2 μm membrane filters before injection (volume 100 μL). In 
the NMR studies, the ratio of the peak intensity of CH2 of the PEG segment (3.6 ppm) to that 
of the CH3 of the cholane core (0.6 ppm) is used for the calculation of molecular weight.  
 
Table 2.1. The molecular weights of the star polymers CA(EGn)4 determined by SEC, 
MALDI-TOF mass spectrometry, and 1H NMR spectroscopy 
a The degrees of polymerization (n) are calculated from Mn by SEC. 
 
2.3.2. Sample Preparation  
Samples for self-diffusion measurements were prepared following a method described 
previously.6, 9 A D2O solution containing 1 wt % of a diffusing probe (in this case the star 
polymers) was added to poly(vinyl alcohol) (PVA) weighed in a 5-mm-o.d. NMR tube. The 
concentrations of the star polymers are much lower than their critical aggregation 
concentrations (CACs) determined by surface tension measurements.21 The final 
concentrations of the matrix, PVA, ranged from 0 to 0.25 g mL-1, at an increment of 0.05 g 
mL-1. Molal concentration (mole of solute per 1000 g of solvent) is used in this work because 
of its convenience in the preparation of samples. Note that for dilute solutions, the 
Samples a 
SEC  MALDI-TOF  1H NMR 
Mn 
(g/mol) 
PDI 
 
 
Mn 
(g/mol) 
PDI 
 
 
Mn 
(g/mol) 
CA(EG4)4 1110 1.04  1360 1.03  1410 
CA(EG6)4 1510 1.04  1810 1.03  2180 
CA(EG10)4 2190 1.04  2430 1.03  3140 
CA(EG17)4 3500 1.03  4230 1.03  5490 
CA(EG31)4 5870 1.05  5980 1.03  8600 
CA(EG39)4 7320 1.03  6860 1.02  11340 
CA(EG54)4 9890 1.05     15450 
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concentration in molality is close to that in molarity. The samples were sealed and heated at 
110 oC for 24 h.  
 
2.3.3. NMR Measurements of Self-Diffusion Coefficients 
The stimulated echo pulse sequence developed by Tanner (STE: 90-t1-90-t2-90-t1-echo) 
was used to measure the self-diffusion coefficients (D) of the star polymers.25 Measurements 
were performed at 23 oC on a Bruker AV400 NMR spectrometer operating at a frequency of 
400.27 MHz for protons. The self-diffusion coefficients (D) were obtained from the following 
relationship26-28 
2 2 2 ( 3)
0
G DA A e γ δ δ− Δ−=                                                     (2.1) 
where A0 and A are the NMR signals in the absence and in the presence of the gradient pulses 
of strength G, respectively, γ the gyromagnetic ratio of 1H, δ the duration of the applied 
gradient pulses, and Δ the time interval between the two gradient pulses.  
The interval Δ between the gradient pulses was fixed to 100 ms, the duration of the 
gradient pulse was set at 1 ms. The gradient strength was varied in 16 steps within a range 
from 0.1 to 10 T/m (the minimum and maximum varied depending on the system studied) to 
achieve an attenuation of at least 80% for the diffusants. The gradient was applied along the z 
axis. For selected samples, the self-diffusion coefficients were also measured in the x and y 
direction and the self-diffusion was found to be isotropic. The mean-squared displacement in 
one dimension can be estimated by 2D(Δ – δ/3). Since the typical self-diffusion coefficients 
are of the order of magnitude of 10-11 m2/s, at Δ = 100 ms the root-mean-squared 
displacements are substantially larger than the radius of gyration of either monomeric 
diffusants or their micellar aggregates. Therefore, the self-diffusion coefficients measured by 
PGSE NMR experiments reflect the center-of-mass diffusion. The model of Petit et al.29 was 
used to fit the experimental data. The coefficients of determination (R2) obtained were in the 
range of 0.989−0.999.  
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2.3.4. T1 Measurements 
A standard inversion-recovery pulse sequence (180ox – τ – 90ox – ACQ) was used to 
determine the longitudinal relaxation time (T1) of the characteristic groups of the diffusants. 
The T1 measurements at variable temperatures (10 – 70 oC) were carried out on a Bruker 
AV400 NMR spectrometer. The T1 measurements of the solutions with different 
concentrations were performed at 25 oC. A total of 16 increments of the recovery delay times 
(τ) between 0.01 and 4 s were used and 8 scans were accumulated for all measurements.  
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Figure 2.2. Self-diffusion coefficients (A) and reduced self-diffusion coefficients (B) of the 
star polymers as a function of PVA concentration at 25 oC. CA(EG4)4, (□); CA(EG6)4, (○); 
CA(EG10)4, (∆); CA(EG17)4, (×); CA(EG31)4, (◇); CA(EG39)4, (✳). The lines are fits to Eq. 
2.2.  
 
2.4. Results and Discussion 
2.4.1. Diffusion Behaviors in PVA-Water-Diffusant Tenary Systems 
Figure 2.2 shows the effect of PVA concentration on the self-diffusion coefficients of the 
star polymers. Both the increase in viscosity and hydrodynamic interactions contribute to the 
29 
 
substantial decrease in their diffusion coefficients with increasing PVA concentration. In the 
aqueous solutions, the hydrogen bonding between PVA and the ethylene glycol moieties can 
be neglected.8 A higher PVA concentration generally means more obstructions for the 
diffusants.30 The PVA network used in the study have a correlation length in the range of 0.4 
– 3 nm,5 which is smaller than or similar as the hydrodynamic radius, RH, of the probes (1.3 – 
3.1 nm, as obtained from Stokes-Einstein relation) (Table 2.2). Although the star polymers 
show similar trend as linear PEGs6 and poly(propylene imine) dendrimers,9 an increase in 
PVA concentration causes a larger decrease in the self-diffusion coefficient of the linear 
PEGs in comparison to the CA(PEG)4 stars and the dendrimers of similar molecular weight.  
The size of the diffusants has a clear effect on their self-diffusion coefficients in 
polymers.6, 8-10, 13, 18 The self-diffusion coefficients D are normalized with their values in pure 
water (D0) and the results in Figure 2.2B clearly show that the D/D0 values decrease faster in 
the PVA concentration range of 0 – 0.15 g/mL with increasing MW of the star polymers. The 
change of diffusion coefficients is more significant for the molecules of higher molecular 
weight and larger size, which are expected to interact more extensively with the PVA matrix.  
The experimental values of the self-diffusion coefficients as a function of PVA 
concentration can be fitted with the model of Petit et al.29 
0
1
DD
ac ν−
= +                                                               (2.2) 
where a = D0/(kβ2), ν and β are constants which are characteristic of the polymer-solvent 
system, k represents the jump frequency over the energy barriers, which is expected to depend 
on the temperature and on the size of the diffusant, and c is the polymer concentration. In this 
model, the polymer solution is treated as a statistical network. 
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Table 2.2. Self-diffusion coefficients (D0), hydrodynamic radii (RH), and fitting parameters 
kβ2 and ν obtained for the star polymers CA(EGn)4 in PVA-water-diffusant ternary systems 
sample 
Mna 
(g/mol) 
D0 (10-10m2/s) Ds,0 
(10-10m2/s) 
RH 
(nm)c 
νb 
kβ2 
exp. calcd.b (10-11 m2/s)b 
Star polymers 
CA(EG4)4 1110 1.92 1.92  1.28 0.65 1.17 
CA(EG6)4 1510 1.66 1.66 1.60 1.48 0.66 0.82 
CA(EG10)4 2190 1.45 1.45  1.69 0.65 0.65 
CA(EG17)4 3500 1.04 1.04  2.36 0.70 0.35 
CA(EG31)4 5870 0.88 0.88 0.85 2.79 0.58 0.40 
CA(EG39)4 7320 0.79 0.79 0.78 3.10 0.56 0.31 
Linear polymers 
PEG-600 1100 (530) 1.86 1.87  1.32 0.58 1.20 
PEG-1000 1220 (970) 1.66 1.66  1.48 0.49 1.20 
PEG-1500 1600 (1460) 1.13 1.13  2.17 0.54 0.68 
PEG-2000 1960 (2140) 1.07 1.02  2.29 0.53 0.53 
PEG-4000 4050 (4430) 0.96 0.96  2.55 0.50 0.47 
PEG-8000 9100 (8000) 0.64 0.65  3.83 0.60 0.10 
Dendrimers 
PPI(TEG)8 2000 1.64 1.64  1.49 0.59 0.79 
PPI(TEG)32 8600 0.91 0.91  2.69 0.68 0.16 
PPI(TEG)64 17000 0.70 0.69  3.50 0.69 0.10 
a For CA(EGn)4, the Mn values were measured by SEC-RI in THF. For linear PEGs, the Mn 
values were measured by SEC in THF and in water (values in parentheses).6, 10 For the 
dendrimers, the Mn values were measured by 1H NMR spectroscopy.9 b Obtained as a fitting 
parameter from eq. 2.2. c Calculated from Stokes-Einstein equation. 
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The values obtained for the parameters, D0, kβ2, and ν are listed in Table 2.2. The D0 
values obtained from fitting agree well with the experimental data, with a clear dependence 
on the molecular size of the diffusants. The parameter ν is dependent on the solvent and falls 
in the range of 0.50 – 0.70 for the ternary system, indicating water is a marginal solvent for 
PVA.29 The parameter kβ2 decreases with increasing hydrodynamic radius of the diffusing 
star polymers (Table 2.2). Since β should remain constant for a given polymer-solvent 
system,29 the results indicate that an increase in the size of the diffusant (RH) leads to a lower 
jump frequency k. Similar decreasing trend was obtained with the linear PEGs6 and 
PPI(TEG)n dendrimers.9 At a comparable RH value, the kβ2 parameter varies according to the 
general order of linear > star > dendrimer. This implies that the linear PEGs have a higher 
jump frequency than the diffusants in the other two series of comparable molecular size. 
When the RH is larger than ca. 2 nm, the kβ2 values of both dendrimers and star polymers 
decrease more slowly since the movement of longer linear chains is hindered more 
substantially than the corresponding star-shaped polymers and dendrimers. 
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Figure 2.3. Logarithmic plot of the hydrodynamic radius RH as a function of molecular 
weight for linear PEOs (■, data from reference31), dendrimers (●, data from reference9), and 
the star polymers (★) in aqueous solutions at 23 oC. Good linear relations were observed 
with the coefficients of determination (R2) of 0.9983, 0.9998, and 0.9855, respectively. 
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2.4.2. Scaling Relation between the Hydrodynamic Radius and the Molecular Weight of 
the Diffusant in Water-Diffusant Binary Systems 
Logarithmic plots of RH versus M for linear PEOs, CA(EGn)4 star polymers, and the 
dendrimers are shown in Figure 2.3, with the slopes of the linear fitting being 0.57, 0.47, and 
0.40, respectively. The star polymers essentially present a random coil conformation as some 
flexible linear polymers, whose scaling constant of the relation, RH ~ Mν, falls in the range of 
0.5 ~ 0.6.15, 32, 33 Globular proteins,34 star polymers,35, 36 and dendrimers37-40 normally have a 
scaling constant of 0.3 ~ 0.4 due to the globular shapes and the compact, space-filling nature. 
However, the scaling parameter of star polymers varies, and some star polymers such as 4 to 
16-arm poly(ethylene oxide)s from carbosilane dendrimers have a scaling constant of 0.5.41 
Linear PEOs have slightly lower hydrodynamic radii than the corresponding CA(EGn)4 star 
polymers at low molecular weight due to the presence of a large cholane core in the star 
polymers. When the molecular weight is further increasing, RH of the star polymers increases 
at a lower rate because the linear PEOs have a more extended structure in solution.42 Since 
the molecular weights of star polymers are usually underestimated using SEC-RI calibrated 
with linear homologues,43 SEC-LS was used to determine the absolute molecular weights of 
the star polymers. The comparison of the results obtained with both detectors shows that the 
absolute molecular weights measured by SEC-LS are 1.1 times of the values obtained by 
SEC-RI. Thus, the linear relation shown in Figure 2.3 also holds if the absolute molecular 
weights of the star polymers are used. The density of dendrimers is higher than those of 
branched and linear polymers due to their dense intramolecular packing, thus RH increases 
slowly with higher Mn, as shown by PPI(TEG)n dendrimers in Figure 2.3. The observation 
agrees well with increasing molecular density of the dendrimers with higher generation 
numbers.9  
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Table 2.3. Molecular weights and hydrodynamic radii of the polymers shown in Figure 2.4A.  
Polymer 
Mn (g/mol) RH 
(nm) SEC NMR
CA(EG31)4 5870 8600 2.8 
CA(EG54)4 9900 15460 4.1 
Linear PEO-6ka 6000 6200 5.6 
Linear PEO-10ka 10000 10600 7.1 
a Mn and RH values of the linear PEOs are from reference20 and the same nomenclature is 
employed. 
 
2.4.3. Effect of Diffusant Concentration on the Self-Diffusion Coefficient in Water-
Diffusant Binary Systems 
For a better understanding of the system, the self-diffusion coefficients of the probes 
were measured in the absence of a polymer matrix, with representative results of selected 
samples (Table 2.3) shown in Figure 2.4A. For the star polymers CA(EGn)4, the self-diffusion 
coefficient decreases significantly with increasing concentration of the diffusants in solution 
(Figure 2.4A). The decrease is more significant for those with higher molecular weights. de 
Gennes’ prediction of a scaling regime 1.75D c−∝  in semidilute solution44 is not apparent in 
the molecular weight range from CA(EG6)4 (Mn = 1510 g/mol) to CA(EG54)4 (Mn = 9890 
g/mol). No c* (overlap concentration) can be defined for the star polymer of low molecular 
weights, such as CA(EG6)4. The self-diffusion coefficient of CA(EG6)4 decreases only 
slightly with increasing concentration. Similarly, previous work of Callaghan and Pinder 
showed that no semidilute regime was observed in the case of low MW linear polystyrene 
(MW = 2000) in CCl4.33  
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Figure 2.4. (A) The dependence of self-diffusion coefficient D on the concentration of 
polymer diffusants in water: CA(EG6)4 (✳) (Mn = 1510), CA(EG31)4 (☆) (Mn = 5870), 
CA(EG54)4 (★) (Mn = 9890), linear PEO-6k (□), linear PEO-10k (■). Sample details are 
given in Table 2.3. Data of PEO-6k and PEO-10k are from reference.20 (B) Variation of 1/D 
as a function of concentration of the star polymers. Sample details are given in Table 2.2. The 
lines are fits to Eq. 2.3 and the derived self-diffusion coefficient at infinite dilution (Ds,0) are 
shown in Table 2.2. (C) Variation of Ds,0 as a function of molecular weight of the star 
polymers in D2O at 23 oC (★), linear PEGs in D2O at 25 oC45 (□), and linear PEGs in D2O at 
30 oC46 (○). A scaling behavior Ds,0 ~ Mn was observed with the scaling indices of 0.41, 0.60, 
and 0.43 for the star polymers and linear PEGs at 25 and at 30 oC, respectively. 
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For comparison purposes, Figure 2.4A also shows the literature data for linear PEOs.20 
The molecular weights and hydrodynamic radii of these polymers are summarized in Table 
2.3. Diffusion coefficient measurements of two star polymers and two linear PEOs show 
similar decreasing trend within the concentration range of 0 – 40 millimolal. At very low 
concentrations (< 5 millimolal), CA(EG54)4 (Mn = 9890) overlaps with linear PEO (Mn = 
6000). At higher concentrations, the star-shaped diffusants showed slower diffusion than their 
linear homologues. Differences are expected between the star polymers and linear PEGs due 
to the presence of the hydrophobic core of the star polymers. Micelles can form in solutions 
above the CAC of the star polymers. According to surface tension measurements,21 the CAC 
of CA(EG31)4 is ca.19 millimolal and the value for CA(EG54)4 may be slightly higher than 
this number because it is overall a more hydrophilic molecule. A comparison between 
CA(EG17)4 and its n-alkyl poly(ethylene glycol) ether surfactant counterpart with similar 
molecular weight, C17EG84 (17 is the number of carbons in the alkyl chain and 84 the number 
of ethylene oxide units, with a CAC at 2.5 μM),47 shows that CA(EG17)4 (with a CAC at 16 
millimolal) starts to aggregate at a much higher concentration. Therefore, at a similar 
molecular weight, the star polymer is much less hydrophobic than such a linear amphiphilic 
polymer and does not aggregate as easily.  
A scaling relationship between the self-diffusion coefficient at infinite dilution and the 
molecular weight for a given diffusant, ,0
n
sD M
−∝ , originally proposed by Flory,48 was 
observed for star polymers CA(EGn)4 dissolved in D2O at 23 oC. The values of Ds,0 of 
CA(EGn)4 were determined from the initial linear region of a plot of D-1 versus c (Figure 
2.4B) by fitting to the first-order expression of  
1 1
,0 (1 ...)s fD D k c
− −= + +                                                         (2.3) 
where kf and similar higher order coefficients are independent of c.33 Logarithmic plots of Ds,0 
versus molecular weight (Figure 2.4C) show that the CA(EGn)4 series has a scaling exponent 
n of 0.41. The scaling exponent of the star polymers is very close to the value of low 
molecular weight linear PEGs (monomer to N-mer of 40) at 30 oC (n = 0.43) reported in a 
study by Shimada et al.46 The scaling factor obtained from another study by Blum et al. is 
0.60 for linear PEGs in D2O at 25 oC.45 In this temperature range, the small differences in 
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temperature would have little effect on the self-diffusion coefficients of the polymers. The 
difference may be explained by the different molecular weight range (dimer to N-mer of 
14,000) covered in the work of Blum et al.45 and the high polydispersity for PEGs with high 
molecular weight. Similar to the cases of the linear and star PEGs, a report regarding linear 
and 3-armed polybutadienes showed no qualitative difference in self-diffusion coefficient 
between the two systems.15 
 
2.4.4. The Longitudinal Relaxation Times of the Diffusants (T1) 
T1 values provide additional information about the molecular dynamics of polymers in 
solution.49 The 1H NMR T1 values of two polymers (CA(EG31)4 and CA(EG54)4) at different 
concentrations were measured at 23 oC. With increasing concentration of the star polymers, 
the T1 value of methylene protons on the PEG chain decreases while that of the methyl group 
protons on the cholane core increases slightly (Figure 2.5A). The changes of the T1 values for 
the larger CA(EG54)4 are more pronounced. The temperature dependence of T1 was also 
studied in order to clarify the relation between the mobility of the PEG moieties and the 
concentration of CA(EGn)4. In the range of 10 – 70 oC, T1 values of the methylene protons on 
the PEG segments of CA(EG54)4 at selected concentrations increase significantly with an 
increase in temperature, while those of the methyl protons of the cholane core first decrease 
and then increase within this temperature range (Figure 2.5B). In the Bloembergen-Purcell-
Pound theory (BPP theory), T1 shows a minimum along with the correlation time (τc, 
decreasing mobility).50 The results indicate that these PEG methylene protons lie in the fast 
motion regime (where T1 increases with increasing mobility), while the cholane core is in the 
intermediate motion regime (where T1 is close to the minimum in the plot of T1 vs τc). This 
mobility difference between the core and PEG chains of star polymers CA(EGn)4 is similar to 
that observed for the core and the exterior of poly(propylene imine) dendrimers,51, 52 which 
suggests that the star polymers behave similarly in solution as the dendrimers. Star polymers 
CA(EGn)4 are amphiphilic and tend to form micelles in solution. However, no critical 
aggregation concentration or temperature was observed by NMR for such polymers. The 
micelles and the star polymers are in a dynamic process between free and aggregated states. 
The mobility reflected from the T1 relaxation times is only an averaged observation.  
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Figure 2.5. The 1H T1 values for CH2 of PEG chains (triangles) and CH3 of the cholane core 
(squares) measured for the star polymers. (A) Effect of concentration for two polymers 
CA(EG31)4 (closed symbols), CA(EG54)4 (open symbols) at 25 oC; (B) Effect of temperature 
for CA(EG54)4 at 1.2 (open symbols) and 19.1 millimolal (closed symbols). The inset shows 
the variation of the T1 values of CH3 of the cholane core near the minimum with a different 
scale. The error of the T1 values is estimated to be ±10 ms by multiple experiments. 
 
2.5. Conclusion 
In an effort to understand the effect of molecular shape and architecture of polymeric 
diffusants on the diffusion in polymer hydrogels, we have compared the diffusion behaviors 
of PEG-based macromolecules including linear and star-shaped polymers and dendrimers in 
aqueous solutions and PVA gels. The results show that the star polymers have an 
intermediate diffusion rate or jump frequency that is higher than the dendrimers but lower 
than linear polymers at comparable hydrodynamic radii. In the dilute regime of the binary 
system, star polymers have the similar diffusion behavior as linear PEGs. In the semidilute 
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regime, a difference between the star polymers and their linear homologues is observed due 
to the presence of the hydrophobic core of the stars. For both 4-armed star polymers and 
linear PEGs, similar scaling relationships are found between the self-diffusion coefficient at 
infinite dilution and the molecular weight of the diffusants. The dependence of the 1H T1 
values of the star polymers on temperature and concentration indicates that the cholic acid 
core of the star polymers is less mobile than the PEG arms. The understanding of the effect of 
molecular shape of the diffusants may help in designing molecules and biopolymers with 
predictable properties for applications such as drug delivery and tissue engineering.  
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3. NMR Imaging Study of Cross-linked High Amylose Starch 
Tablets: Effect of Drug Loading* 
 
3.1. Abstract 
NMR imaging techniques were used to study the effect of drug loading in cross-linked 
high amylose starch tablets. The tablets contained acetaminophen with loading levels from 10 
to 40 wt%. The absolute amount of the drug released increased with larger amount of drug 
loading, but the percentages of drug released had only minor differences for the different 
tablets, probably due to the rapid formation of a gel layer for all the tablets, which slowed 
down drug release significantly. The releases of drugs from the tablets in all cases are 
dominated by a diffusion mechanism before the disappearance of the dry core of the tablets. 
Radial and axial swelling and water uptake were found to increase with the amount of drug 
loading. The diffusion rates of water were comparable at the initial stage for all the tablets 
with different loadings, but became faster later for the tables with higher amounts of drug 
loading as water diffusion may be facilitated by the hydrophilicity of the drug.  
 
3.2.Introduction 
Cross-linked high amylose starch (CHAS) has been demonstrated to be an effective 
controlled release matrix.1-4 Once the CHAS tablets are hydrated, a consistent gel layer is 
formed very rapidly around the tablet core, leading to retarded release of drugs.5 The integrity 
of the CHAS tablets is sustained for over 48 h.6 We have used NMR imaging to study the 
effects of tablet size, temperature, and drug loading on the tablet swelling and water 
diffusion.5-8 The effect of moisture content on the swelling of high amylose starch films was 
also studied using NMR imaging by Russo et al.9 In addition, the conversion from V-type 
(single helix) to B-type (double helices) which limits the swelling of starch was also revealed 
by CP-MAS 13C solid-state NMR spectroscopy.10  
The drug release mechanism is classified into three cases: diffusion mechanism, polymer 
relaxation mechanism, and a mechanism which lies between the two cases. It was found for 
ethyl cellulose tablets that drug release is controlled by a diffusion mechanism at a high 
loading of acetaminophen (APAP) (49.5 wt %), while the effect of the polymer relaxation 
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becomes significant at a low loading (9.9 wt %).11 In the case of poly(ethylene oxide) (PEO) 
tablets, the drug dissolution and diffusion through the swollen gel layer controlled the release 
at a loading levels of 39% and 20%, respectively.12 Previously we have studied the release of 
two drugs, ciprofloxacin and acetaminophen, loaded at 10 wt% in CHAS.5 The amount of 
drug loading may also have a significant effect on the amount released from the polymer 
tablets. APAP is an analgesic (pain reliever) and an antipyretic (fever reducer), which has 
been used as a probe to study controlled release properties of some matrices, including 
hydroxypropyl methyl cellulose (HPMC),13 HPMC-polyvinylpyrrolidone,14 and high-amylose 
sodium carboxymethyl starch matrices.15 We also chose APAP in this study with loadings of 
10, 20, and 40 wt % in the CHAS tablets. In vitro drug release from the matrix tablets was 
determined and the results were correlated with swelling and water uptake of the tablets. The 
diffusion coefficients of water can be obtained from profile fitting and diffusion-weighted 
NMR images.  
 
3.3. Experimental 
3.3.1.Preparation of Tablets 
The polymer (CHAS) was made of chemically modified high amylose starch (70% 
amylose), cross-linked with 0.075 wt % phosphorous oxychloride in a mild alkaline medium 
first and further functionalized with 6 wt % of propylene oxide followed by washing and 
drying. Gelatinization of the starch under 160 oC and 5.5 bars was then conducted 
immediately prior to spray-drying. Appropriate amount of granulated acetaminophen 
(Compap, MW 151 g/mol, Rh 0.37 nm) and CHAS were mixed for 4 minutes. The blend was 
compressed to form tablets of 200 mg each with a dimension of 9.0 mm × 3.0 mm. To 
achieve the target weight and thickness for the tablets, the press parameters were adjusted to 
1330 kg/cm2 for 10 – 20 wt % drug loadings and 785 kg/cm2 for 40 wt % drug loading along 
the axial direction. Dosages with drug loadings of 10, 20, and 40 wt % were obtained. 
 
3.3.2. NMR Imaging 
All NMR imaging experiments were carried out at 37.0 oC on a Bruker Avance-400 
NMR spectrometer operating at a frequency of 400.27 MHz for protons equipped with a 
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microimaging probe having a 20 mm inner diameter. A standard spin–echo pulse sequence 
was used to obtain spin density images of the tablets in a 20 mm o.d. NMR tube containing 
20 mL of distilled water. A slice of 0.5 mm in thickness was selected either perpendicular or 
parallel to the main magnetic field using a sinc-shaped pulse. Eight scans were accumulated 
to obtain 128 × 128 pixel images for a field of view of 2.0 cm, leading to an in-plane 
resolution of 156 μm. An echo time (TE) of 3 ms and a repetition time (TR) of 1 s were fixed 
leading to an acquisition time of about 17 min for each image.  
Diffusion-weighted images were acquired by combining the spin-echo pulse sequence 
with the pulsed-gradient spin-echo (PGSE) pulse sequence developed by Stejskal.16 The 
diffusion time (Δ) and the length of the gradient pulse (δ) were 10 ms and 2 ms, respectively. 
The gradient strength varied from 5 to 100 G/cm.  
 
3.3.3. Solubility Tests of CHAS 
The CHAS powder (300 mg) was mixed with 20 mL distilled water in a 50 mL 
centrifuge tube, which was then placed in a shaking bath and agitated at 100 rpm and 37 oC 
for 30 minutes. The samples were centrifuged (4000 rpm, 1 h) and the supernatant was 
collected and dried at 70 oC for soluble fraction quantification. The test was performed in 
triplicate.  
 
3.3.4.Water Uptake Experiments 
Water uptake studies were carried out in a water bath at 37 oC with mild agitation. Each 
tablet was immersed in 20 mL distilled water and the weight was measured in triplicate at 
predetermined time intervals. The percentage of mass uptake is defined as 
0
0
100%tt
M MS
M
−= ×                                                        (3.1) 
where St is the water uptake in percentage, M0 and Mt are the initial weight of a tablet and its 
weight at time t, respectively. 
 
3.3.5.In Vitro Drug Release Tests 
The tablets were placed individually in 900 mL of distilled water at 37 oC in a U.S.P. 
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XXIV dissolution apparatus 2 (Distek Premiere 5100 dissolution system) equipped with a 
rotating paddle (100 rpm). The amount of drug released from the tablet in a 24-h period was 
determined spectrophotometrically (244 nm) at an interval of 30 min. The sampling liquid 
flowed back to the vessels. All tablets were tested in triplicate.  
The fitting of the data from NMR imaging experiments and of the drug release tests was 
carried out with Microsoft Excel 2003 using the Newton method to minimize the sum of the 
squared errors. A summation of 30 roots of the Bessel function was used.  
 
3.4. Results and Discussion 
Figure 3.1 shows the NMR images of CHAS tablets acquired from 1 to 20 h in water at 
37 oC. A gel layer formed quickly within a few minutes after the tablets came into contact 
with water. All three images at 1 h clearly show the gel layer, the hydrated layer, and the dry 
core (with the lowest water signal). The formation of the gel layer is essential for the 
controlled release of the CHAS tablets. The apparent high water signal shown by the 
periphery of tablets is caused by the shorter longitudinal relaxation time T1 (ca. 800 ms) of 
the hydrated layer compared with that of the free water (ca. 5 s). As the water front advanced 
towards the center, the dry core gradually diminished in dimension with immersion time. The 
effect of drug loading levels is visible on the images acquired at 5 h and onward. At 20 h, 
water is distributed almost evenly in the tablet of 40% APAP, while the tablet of 10% APAP is 
still far from reaching equilibrium (Figure 3.1). NMR imaging experiments showed the 
tablets with 10% APAP loading reached equilibrium after 50 h. Therefore, the diffusion of 
water inside the tablets depends on the amount of APAP inside. It is to be noted that the 
movement of water into the tablet in the presence of the drug may not be strictly diffusional 
as the contribution of osmotic convection at the beginning stages of the process is present.  
Figure 3.2A shows the mass uptake of tablets. Overall, the amount of mass change is 
contributed by the weight gain due to water diffused into the tablets and the weight loss due 
to drug release from the tablets. The solubility of CHAS in water (2.6 mg/mL) is much lower 
than that of APAP (14.5 mg/mL, USP XXIV) so that the amount of dissolved CHAS can be 
neglected, but frequent manipulations may also cause weight loss and thus the mass uptake 
may be underestimated. In general, the tablets with higher amount of drug loading had a 
lower gain in mass. The difference between the mass uptake at equilibrium is close to the 
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difference between drug loading level. The tablet with low drug loading had a faster increase 
in mass and reached an equilibrium earlier in time. Clearly, the tablets of 40% APAP undergo 
the highest weight loss due to drug release. In addition, the gel layers formed on these tablets 
are softer than the gel layers formed on tablets with lower drug loading levels, which is 
clearly visible, so that these layers are less resistant to erosion.  
 
 1 h 2 h 5 h 10 h 15 h 20 h  
 
 
10% 
   
20% 
    
40% 
   
Figure 3.1. NMR images of CHAS tablets immersed in water at 37 oC for 1, 2, 5, 10, 15, and 
20 h. The part at the bottom of images is the Teflon support.  
 
Table 3.1. The initial diffusion coefficients of water fitted to Eq. 3.2 and the average diffusion 
coefficients fitted to Eq. 3.5 in the CHAS tablets. 
drug loading 
(%) 
axial D0 radial D0  0D  D∞  
(10-11 m2﹒s-1) (10-11 m2﹒s-1)  (10-11 m2﹒s-1) (10-11 m2﹒s-1) 
10 6.5 ± 0.2 5.2 ± 1.1  2.4 ± 0. 2 13.6 ± 2.1 
20 7.1 ± 0.4 3.3 ± 0.6  1.82 ± 0.04 12.3 ± 0.1 
40 7.6 ± 0.3 4.2 ± 0.5  2.0 ± 0.2 16.2 ± 2.5 
 
Figures 3.2B and 3.2C show the radial and axial swelling of the tablets, respectively. The 
axial swelling is almost 3 times of the radial swelling for all the tablets, which has been 
observed for the CHAS tablets with and without the drug.5, 6 The higher axial swelling is 
caused by the compression along the axial direction during the preparation process. To 
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prevent the floating and movements of the tablets in the liquid media, a piece of cotton ball 
was placed above the tablet to keep it in place during the NMR imaging experiments, which 
may have caused the relatively higher standard deviations of axial swellings in comparison to 
those of radial swellings. The tablets with 10% loading has the lowest swelling, while the 
other two swell at a similar rate and reached a similar size. The drug APAP has a higher 
hydrophilicity than the matrix, which facilitates the penetration of water and enhances the 
overall swelling in both axial and radial directions.  
The measurement of diffusion coefficients of water (D) inside of the CHAS tablets may 
provide quantitative information on the effect of drug loading on the mobility of the polymer 
matrix. The initial diffusion coefficient of water can be obtained from the water proton image 
profiles, an example of which is shown in Figure 3. At the initial stage of swelling, a tablet 
can be treated as an infinite cylinder in which water diffusion follows Fick’s second law of 
diffusion.6, 17 The initial diffusion coefficients of water (shown in Table 3.1) can be obtained 
from fitting the data to 
2
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nD t
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n n n
J x rC e
C J
⎛ ⎞−∞ ⎜ ⎟⎜ ⎟⎝ ⎠
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= − ∑
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α α                                         (3.2) 
where C and C0 are the concentrations of water at distance x and at the surface of the 
cylinder, respectively, r is the radius of the cylinder, D the diffusion coefficient of water, t the 
immersion time, J0 Bessel function of the first kind of the order 0, J1 the Bessel function of 
the first kind of the order 1, and αn the nth root of J0 = 0.18-21 
At the beginning of immersion, the assumption of infinite cylinder is applicable and good 
fits to Eq. 3.2 can be easily obtained, as exemplified by Figure 3.3. The initial diffusion 
coefficients of water in CHAS tablets are comparable for all three tablets with different drug 
loading levels along both directions (Table 3.1). But significant deviations from the model 
were observed with the further advancement of water inside the tablets. Alternatively, the 
average diffusion coefficient ( D ) can be calculated from mass uptake by substituting the kd 
value obtained from Eq. 3.3 into Eq. 3.4:17, 22  
n
d
M k t
M∞
=                                                                  (3.3) 
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2
4
dk rD π⎛ ⎞= ⎜ ⎟⎝ ⎠                                                              (3.4) 
where M and M∞ are the amounts of water penetrated in a tablet at time t and at equilibrium, 
respectively, and kd is a parameter related to the diffusion.  
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Figure 3.2. Mass uptake (A), radial swelling (B), and axial swelling (C) of the CHAS tablets 
loaded with 10% (□), 20% (○), and 40% acetaminophen (∇). Note that the mass uptake is the 
combined effect of mass gain by the absorption of water and the mass loss by the release of 
the drug. 
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Figure 3.3. The water proton spin density profile (solid line) and the fit to Eq. 3.2 (dashed 
line) of a CHAS tablet with 20% acetaminophen swelled in water at 37 oC for 30 min.  
 
Mass uptake could be obtained from either gravimetric analyses or the integration of 
water signals in NMR images. The tablets become fragile after immersion in water, and 
manipulations during the weighing process may introduce errors, yielding less consistent 
results than the integration of signals of the NMR images. The latter method may be also 
difficult to apply for the system here, since Eq. 3.3 becomes invalid at ca. 60% of water 
uptake,9, 23 which can be accomplished within 3 h for the tablets. The rapid water uptake 
during the first 3 h and the long acquisition time of each image with good S/N ratio (17 min) 
add up to the difficulty of obtaining an accurate D .  
To overcome such difficulties, diffusion-weighted images were acquired from which 
average diffusion coefficients may be obtained. This method produces images weighted with 
the local characteristics of water diffusion. The diffusion coefficients of both the gel part and 
the core of the tablets with various drug loading levels are shown in Figure 3.4. Reliable 
values of D cannot be obtained for an immersion time of less than 10 h when the signal 
attenuation is too low to be accurately detected even if a high gradient strength is applied. The 
figure shows that the self-diffusion coefficients of water in the outer gel changes only slightly 
with time and the values are comparable for different tablets, while those in the inner part of 
the tablets changed with time and vary significantly with different drug loading levels. The 
signal in the core for the tablets with 40% drug loading increased faster than the tablets of 
lower loadings. The faster water diffusion in these tablets agrees well with the faster swelling 
of the tablets. Since APAP is more hydrophilic than the CHAS matrix, a higher loading of 
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APAP facilitates the diffusion of water towards the core.  
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Figure 3.4. Diffusion coefficients of water in the inner core of the tablets loaded with 10% 
(□), 20% (○), and 40% acetaminophen (∇) obtained by diffusion-weighted imaging. The 
values corresponding to the hydrated gels of the tablets are shown by closed symbols. 
 
The percentage of drug released at 37 oC (Figure 3.5A) shows only minor difference 
among the tablets of different drug loading levels, even though the absolute amount of the 
drug released are very different (Figure 3.5B). A small initial burst could be attributed to 
release of the drug at the surface and surface erosion of the matrix prior to the formation of a 
gel layer. The drug release curves can be fitted to the equation F = k tn. The value of power 
index n serves as a criterion to determine whether the release is controlled by a diffusion 
mechanism (n = 0.5) or polymer relaxation mechanism (n = 1). For the CHAS tablets with 10, 
20, and 40% APAP, the n values are found to be 0.51, 0.55, and 0.56, respectively, indicating 
the drug release process is dominated by a diffusion mechanism in all the tablets.  
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Figure 3.5. Release of drugs of CHAS tablets loaded with 10% (□), 20% (○), and 40% 
acetaminophen (∇). The amount of the drug released is quite different while the percentage 
remained similar.  
 
The average diffusion coefficients ( D ) may be obtained by fitting the dissolution test 
results to the following equation:24  
-2 2 -2 2
2 2
( ) 81 exp(- ) exp(- )
( ) m m n nm n
M t D t D t
M l a
= − α α β β∞ ∑ ∑                        (3.5) 
where M(t) and M(∞) are the amounts of drug released at time t and infinite time, 
respectively; l is the half-thickness of the tablet, r the radius, D the diffusion coefficient; α 
and β are parameters defined in 0 ( ) 0J rα =  and (2 1)2n
n
l
+ πβ = , where J0 is a zero-order 
Bessel function. The model is applicable to tablets of a shape ranging from a flat disk to a 
cylinder. It is important to note that the validity of the equation is based on the hypotheses 
that there is no dimension change of the tablets, no variation of the diffusion coefficient of 
water from outer gel to inner core, and no gradual increase of diffusion coefficients of water 
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in the tablets over time. For comparison purposes, the fitting was performed on two stages, 
yielding the “initial” average diffusion coefficient ( 0D ) using initial dimension of the tablet (l 
and r) during the drug release of 0 – 60% (corresponding to an immersion time from 0 to 3.5 
and 4 hours depending on the amount of drug loading) and the average diffusion coefficient at 
equilibrium ( D∞ ) using the final dimension during the drug release of 80 – 100%, 
corresponding to an immersion time period of ca. 7 to 18 hours. The results are shown in 
Table 3.1. The assumption of a constant diffusion coefficient leads to lower 0D  values than 
those obtained by spin density profile fitting, but still in the same order of magnitude. 
Moreover, the values for 10 – 40% drug loadings are similar to each other, which is consistent 
with the trend obtained from NMRI profile fitting. At equilibrium, the water diffuses much 
faster than at the beginning and thus D∞  is almost an order of magnitude higher than 0D . The 
trend is also reflected by the diffusion-weighted imaging experiments (Figure 3.4). The 
difference between the two series of diffusion coefficients may be explained by the low 
repetition time used during the diffusion-weighted imaging experiments.  
 
3.5. Conclusion 
We study the effect of drug loading for the case of cross-linked high amylose starch with 
APAP. In this case, the amount of the drug released is higher with a higher level of drug 
loading, but the percentage of the drug remained similar, making the prediction of drug 
release easier. This is likely due to the formation of a protective gel layer upon hydration of 
the tablets, which serves as a key factor in such a controlled release process. The NMR 
imaging results also show that the radial and axial swelling and water uptake of the CHAS 
tablets increased with the drug loading level. Diffusion of water is faster for the tables of high 
drug loadings due to the hydrophilicity of APAP, especially at a later stage of the release 
process. The dissolution tests demonstrated that the release of APAP from the CHAS tablets 
followed a diffusion mechanism.  
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4. Swelling Behavior of Chitosan, Carboxymethyl Starch and 
Chitosan-Carboxymethyl Starch Mixture As Studied by NMR 
Imaging* 
 
4.1. Abstract 
The swelling properties of the tablets made of chitosan, carboxymethyl starch and a 
polymer complex based on a mixture of these two polysaccharides were studied by NMR 
imaging. Water and simulated physiological fluids were used to study the effect of pH and 
ionic strength on the swelling of the tablets and on the diffusion of fluid into the tablets. The 
tablets were compared also with those made of cross-linked high amylose starch. The 
capacities to modulate the release rate of drugs in different media was discussed by 
comparing the matrices and evaluating the preparation process of the complex.  
 
4.2. Introduction 
Polysaccharides are among the most abundant macromolecules in nature and present 
several advantageous characteristics for various applications. They are highly stable, non-
toxic, hydrophilic, biodegradable and some of them bioadhesive. The presence of hydroxyl 
groups or amine groups in polysaccharides allows for chemical derivatization and cross-
linking. Improved physicochemical properties can be achieved by chemical modifications. 
For these reasons, drug delivery with solid oral dosage forms has often used polysaccharides, 
such as starch, cellulose, chitosan, collagen and pectin. For example, hydroxypropyl 
methylcellulose (HPMC) is one of the most widely used polymer carriers in the 
pharmaceutical industry. The ratio of hydroxypropyl groups to methoxyl groups can be 
modified to produce HPMC products of different hydrophilicities.1  
Cross-linked high amylose starch (CHAS) is an excellent excipient for controlled drug 
release because the cross-linking keeps the polymeric network from erosion and 
retrogradation and more importantly, restrains swelling of the matrix. The sustained release 
was optimized for a CHAS matrix with a cross-linking degree of 6% (often defined as the 
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weight ratio of the cross-linking agent to the starch).2 The pKa of natural starch is about 12-
14.3, 4 Therefore, pH has no effect on the swelling of the CHAS tablets at pH 2-8 in the 
gastrointestinal tract. Carboxymethyl starch (CMS), on the other hand, is an anionic polymer 
with a pKa of about 4.85 due to the presence of carboxyl groups.6, 7 So that its swelling is 
suppressed in gastric fluid. The resultant oral dosage forms could decrease irritation to 
stomach caused by soluble drugs and increase their bioavailability. In intestine surroundings, 
CMS is deprotonated and the polymer chains swell, leading to the release of the drug 
entrapped in the matrix. CMS was proposed as a pharmaceutical excipient for oral dosage 
forms of bioactive agents such as peptides,8 enzymes9 and probiotics.10 In contrast to starch, 
chitosan is a linear cationic polysaccharide due to the presence of amine groups. Its pKa value 
is about 6.3.11 In acidic media, unmodified chitosan dissolves due to protonation of its amine 
groups. The control of drug release depends on the dissolution rate and this can be modulated 
by the formulation of excipients.  
The pH-dependent drug release can cause in vivo variability, and thus it is difficult to 
correlate in vitro release with in vivo drug availability. Complexation represents an effective 
way to modulate the pH-sensitive swelling of polyelectrolytes. A complex can be formed in 
the presence of chitosan and a polyanionic polymer (such as polysaccharides,12 synthetic 
polymers,13 proteins14 and DNA15).16 The complexation occurs without cross-linking agents, 
catalysts or organic solvents, which alleviates the concerns about safety in the body.16, 17 In 
this study, the complex of CMS and chitosan obtained by direct precipitation has been 
investigated.  
In general, the water uptake properties of anionic and cationic polymeric excipients are 
provided by the ionization of the functional groups, which depends on the pH and on the 
ionic strength of the external medium.18 Although the effect of pH on the swelling of the 
above-mentioned four excipients, CHAS, CMS, chitosan and CMS-chitosan complex, is 
qualitatively predictable, a quantitative study will generate useful information on their 
capabilities to control the drug release. The hydration data will also serve to the modulation 
of the excipient preparation for better reproducibility.  
Nuclear magnetic resonance imaging (NMRI) is one of the ideal methods to record in 
situ the swelling behavior of solid oral dosage forms, thanks to its noninvasive and 
nondestructive nature. Magnetic field gradients are used to encode the spatial distribution of 
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the spin density.19 Researchers can use NMRI to evaluate the polymer concentration profile 
during the swelling of the tablets,20, 21 quantify dimensional properties (thickness, area and 
volume) during the swelling,22-26 and define the diffusion front by a sharp gradient in signal 
intensity.22, 23 Furthermore, the NMRI studies can provide the diffusion coefficient of a liquid 
component,25, 26 and the spin-lattice and spin-spin relaxation times which relate to the 
environment of the penetrant and its physical bonding to the polymer system.27  
We have used NMRI in the study of the CHAS tablets with and without loaded drugs,22-
26, 28 and investigated the effect of temperature, tablet size and the drug loading on the 
swelling and water uptake of the CHAS tablets. In this study, we would like to compare the 
characteristics of the tablets of the four matrices in three different media, i.e., simulated 
gastric fluid (SGF), simulated intestinal fluid (SIF) and water. This should provide a better 
understanding of the polysaccharides used in drug delivery systems. CHAS, a well-
characterized polymer matrix for sustained release of drugs, served as a basis of comparison 
in the study of the other three matrices.  
 
4.3. Experimental Section 
4.3.1. Preparation of Matrices and Tablets.  
High amylose starch (corn starch Hylon VII) was obtained from National Starch Co. and 
cross-linked at 6% with epichlorohydrin as reported.2 The CMS was prepared by the alkali-
catalyzed reaction of the high amylose corn starch with chloroacetic acid as previously 
described.29, 30 The degree of substitution of CMS determined by back-titration method is 
about 0.14.30 Chitosan (Marinard Biotech, Rivière-au-Renard, QC, Canada) was purified by 
solubilization in acetic acid followed by filtration.30 The degree of deacetylation of the 
chitosan was about 80% according to acid-base titration and its approximate molecular 
weight determined by Mark-Houwink-Sakurada method was about 700 kDa.30 A 
stoichiometric CMS-chitosan complex was prepared by coagulation of CMS and chitosan in 
an aqueous medium. The interpolymer complex contains 14 wt% of chitosan. The unloaded 
tablets of 200 mg were obtained by direct compression (2.5 tonnes) of the excipient powder. 
Flat-faced punches and a Carver hydraulic press were used to obtain tablets of 9.6 × 2.1 mm. 
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4.3.2. Preparation of Media.  
Simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) were prepared 
according to USP XXIV,31 without pepsin nor pancreatin being added. SGF (pH 1.2) was 
prepared by dissolving 2.0 g of NaCl in 7 mL of HCl, followed by dilution to 1000 mL. SIF 
(pH 6.8) was prepared by dissolving 6.8 g of KH2PO4 in 250 mL of distilled H2O, and adding 
77 mL of 0.2 M NaOH solution followed by dilution to 1000 mL with distilled water. 
 
4.3.3. NMR Imaging.  
All NMR imaging experiments were carried out at 37.0 oC on a Bruker Avance-400 
NMR spectrometer operating at a frequency of 400.27 MHz for protons equipped with a 
microimaging probe with a 20 mm inner diameter. A standard spin-echo pulse sequence was 
used to obtain spin density images of each tablet in the 20 mm o.d. NMR tube containing 20 
mL of the media (distilled water, SGF, or SIF). A slice of 0.5 mm in thickness was selected 
either perpendicular or parallel to the main magnetic field using a sinc-shaped pulse. Eight 
scans were accumulated to obtain 128 × 128 pixel images for a field of view of 2.0 cm, 
leading to an in-plane resolution of 156 μm. An echo time (TE) of 3 ms and a repetition time 
(TR) of 1 s were fixed, leading to an acquisition time of about 17 min for each image.  
In addition to observing the tablets swell in the same medium until equilibrium, some 
tablets were studied by changing the media: first observing the tablets in SGF for 2 h and then 
in SIF until swelling equilibrium was reached. This was used to simulate the situation of a 
tablet’s transit through the gastrointestinal tract, which is denoted as SGF-SIF hereafter.  
 
4.4. Results and Discussion 
4.4.1 NMR Imaging and Proton Density Profiles.  
NMR imaging provides a visual representation of the spatial distribution of water by 
acquiring signals directly from the protons. Figure 4.1 presents the NMR images of tablets 
based on the CMS-chitosan complex in media of different pH values. The images of the 
tablets made of other excipients are shown in Figures 4.4 - 4.6 in the Supporting Information. 
The image cross-sections clearly demonstrate the time-dependent ingress of water into the 
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polymer matrix. Moreover, the swelling of a tablet in the fluid can be visualized from the 
NMR images. 1H tuning and matching strongly depend on the ionic strength of the sample. A 
buffer solution, such as SGF, often causes de-tuning of the probe and some artifacts in the 
NMR images of the highly ionic samples,32, 33 as observed in some images in Figure 4.1. The 
higher intensity of the water inside the tablets is attributed to the different longitudinal 
relaxation time (T1), 5 s for the bulk water vs. 800 ms for the water inside the tablet. The 
repetition time was fixed at 1 s, so that all the images obtained are T1-weighted. The 
magnetization of the bulk water does not have enough time to return to equilibrium, contrary 
to the magnetization of water inside the tablet, leading to a higher proton signal intensity than 
that of the bulk water initially at the interface of the tablet and aqueous media.  
 
 1 h 2 h 3 h 5 h 7 h 10 h  
H2O 
      
 
max 
 
min 
SGF 
      
SIF 
      
SGF-SIF 
      
Figure 4.1. The NMR images of the CMS-chitosan complex tablets immersed in various 
media at 37 oC for 1, 2, 3, 5, 7 and 10 h. The bright spots above the tablets resulted from an 
abrupt change of magnetic susceptibility at the interface between the gel layer and the liquid. 
SGF-SIF indicates that the tablets were transferred from SGF to SIF after immersion for 2 h 
in SGF. 
 
The proton density profiles shown in Figure 4.2 are taken from the NMR images of the 
samples and offer a clearer picture of magnitude of the water signal as a function of time. The 
profiles were plotted along the radial direction going through the center of the tablets. As 
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mentioned earlier, all the images are T1-weighted due to the short repetition time. Water 
concentration in the gel layer is not strictly proportional to the proton density but the trend is 
correct inside a tablet.  
 
4.4.2. Comparison of Polymer Matrices.  
The NMR images and the proton density profiles show that the CHAS tablets swell at the 
slowest rate among the four matrices. The dry core of a CHAS tablet disappears after 
immersion in a medium for more than 7 hours. The hydrated tablet continues to swell very 
slowly until reaching equilibrium at more than 24 h. As expected, the swelling of the CHAS 
tablet shows little difference in the different external media used since the matrix is stabilized 
mainly by hydrogen bonding. Basket-shaped spin-density profiles with flat bottoms present 
the slow process of water penetration in a CHAS tablet. Low water signals have already been 
detected in the core after 2 hours, long before the polymer concentration becomes 
homogeneous in 10 hours. The signal intensity of the core gradually increases with time.  
In contrast, water moves very fast in CMS and the water fronts meet inside a CMS tablet 
after immersion for only 3 hours. It appears (Figure 4.5) that the CMS tablets lack a well-
defined edge owing to the similar proton density of the loose gel at the periphery. Since SGF 
has a pH lower than the pKa (4.8) of CMS, the carboxyl groups are protonated and the 
resultant hydrogen bonds lead to a polymer network which restricts the movement or 
relaxation of the gel and keeps the integrity of the tablets. The swelling ratio in SGF is the 
lowest for the CMS tablets. These results fit well with previous observation of the shape and 
behavior of the CMS tablets.5, 34, 35 In SIF and water with pH values higher than the pKa of 
CMS, the carboxyl groups are ionized. Hydrogen bonds involving carboxylic groups were 
disrupted and an electrostatic repulsion occurred among polymer chains, allowing water to 
readily diffuse into the hydrogels. A higher swelling ratio was observed. A bump-shaped 
change in the proton density was observed in the hydrated outer layer when the gel is very 
loose, which is common for the CMS tablets in SIF and water (Figure 4.8). The water front 
moves the most slowly in the case of SGF. A sharp “peak” well defines the border of a tablet 
at 0.5 h. The slow rate to reach equilibrium for a CMS tablet in SIF and water shows that the 
anionic matrix may offer limited sustained drug release of drugs. 
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Chitosan dissolved in acidic SGF and a thick layer of transparent gel was formed very 
quickly around the hard core. The core decreases gradually with time while the matrix 
dissolves in the medium. Within 2 h the hydrogel already filled the NMR tube with a 
diameter of 18.2 mm. No proton signal was detected in the dry core until the core completely 
disappeared, as shown by the clear-cut feature of the proton density profile. The chitosan 
tablets rapidly disintegrated in both SIF and H2O, and no NMR image could be acquired to 
allow any measurement of swelling ratio.  
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Figure 4.2. The change of the proton density profiles of the tablets made of the CMS-
chitosan complex immersed in (A) H2O, (B) SGF, (C) SIF, (D) SGF-SIF at 37 oC at different 
immersion times. 
 
A tablet made of CMS-chitosan complex presents swelling characteristics similar to 
those of CHAS, but with slightly faster swelling. The features are very different from those of 
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the individual components, CMS and chitosan. The interaction between CMS and chitosan 
retards the diffusion of water. The tablets of the complex swell much more slowly than those 
of CMS and chitosan. A gel layer was formed more rapidly in SGF than in other media and 
kept expanding until reaching the tube wall in 7 hours (Figure 4.1). The gel is mostly formed 
by chitosan which dissolves in SGF. At the same time, the dry core diminishes faster than in 
the other media. At the 5th hour, the proton density profile shows that the proton signal inside 
the tablets became uniform, while the tablets in the other media needed a few more hours to 
complete the process. When the fluid was changed from SGF to SIF, the volume of the gel 
layer either leveled off or decreased due to the still protonated chitosan having a strong 
interaction with ionized CMS.  
The preparation procedure may help to explain the compact shape of the complex tablets 
in neutral media (H2O and SIF) and their pronounced swelling in SGF. The chitosan solution 
(pH 3.6) was added to the CMS solution (pH 6.8) to prepare the complex. During the mixing 
process, the pH value became close to pKa of chitosan (pH 5.2 − 6.8). The formation of the 
complex was due to the electrostatic interaction between NH3+ and COO- and the hydrogen 
bonds between NH2 and COOH groups. Since at pH 5 – 7 the majority of the amino groups of 
the chitosan were non-ionized while the carboxyl acid groups were ionized (deprotonated) 
when the precipitation took place, the complex formed by the two different types of polymer 
ionized polymer chains contained idle NH2 groups ( not involved in the interaction). In SGF 
(pH 1.2), most of the carboxylic acid groups and the amino groups were protonated, leading 
to the dissociation of the NH3+ and COO- groups. The chitosan (non-associated) in the 
complex exhibited significant swelling. A similar chitosan-based complex with pectin was 
reported36 prepared at pH 5.0 at mixing molar ratios (pectin:chitosan) of 9:1, 7:3, and 1:1. 
The swelling of the complex of chitosan (pKa 6.3) and pectin (pKa 4.0) showed significant pH 
dependence when the molar ratio is high. The pH effect was substantially reduced when the 
molar ratio decreased. 
 
4.4.3. Swelling Characteristics of the Tablets  
The radial and axial swelling data extracted from the images at different immersion times 
(Figure 4.3) provide quantitative information of the change in shape and dimension of the 
tablets. In the case of SGF-SIF treatment, when tablets are switched to SIF at 2 h, a sudden 
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change occurs and the swelling curve is approaching the curve of SIF. This behavior is most 
obvious in the case of the complex tablets (Figure 4.3 E-F).  
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Figure 4.3. The radial and axial swelling of the CHAS tablets (A and B), of the CMS tablets 
(C and D), and of the complex tablets (E and F) in H2O, SGF, SIF, and SGF-SIF. Lines are 
fits to Eq. 2. 
 
The percentage of the swelling of the tablets is defined by  
 0
0
100%d dS
d
−= ×                                                           (4.1) 
where S is the percentage of swelling and d and d0 are the dimensions (thickness or diameter) 
of the tablet at immersion time t and at the beginning, respectively. The swelling data can be 
fitted to  
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 max (1 exp( ))sS S k t= − −                                                         (4.2) 
where Smax is the swelling at equilibrium and ks the rate constant of the swelling process.  
 
Table 4.1. Swelling of the tablets made of CHAS, CMS, CMS-chitosan complex. Parameters 
obtained by fitting to Eq. 4.2. The measurements were carried out on triplicates; the reported 
values are the averages and the uncertainties correspond to the standard deviations. 
media 
radial dimension  axial dimension 
Smax (%) ks (10-5s-1 ) R
2  Smax (%) ks (10-4s-1 ) R
2 
CHAS        
H2O 86.8±1.1 6.1±0.2 0.992  109±3 3.6±0.5 0.877 
SGF 62.2±0.7 7.5±0.3 0.989  91.8±2.1 2.2±0.2 0.894 
SIF 62.2±1.2 8.2±0.4 0.985  96.9±3.1 2.0±0.3 0.886 
SGF-SIF 63.0±0.7 7.4±0.3 0.990  92.7±2.3 2.1±0.3 0.878 
CMS        
H2O 57±8 30±9 0.903  139±7 6.8±1.5 0.932 
SGF 66.6±3.8 8.8±0.8 0.991  109±6 3.0±0.6 0.841 
SIF 103±7 14.2±1.8 0.982  159±4 4.5±0.5 0.963 
SGF-SIF 128±24 4.1±1.0 0.996  135±14 1.8±0.5 0.937 
CHAS-CMS Complex       
H2O 37.1±1.2 9.2±1.1 0.907  92.6±2.1 2.8±0.4 0.890 
SGF 91.4±2.8 9.6±0.8 0.976  229±4 4.6±0.4 0.959 
SIF 61.4±1.1 5.0±0.2 0.987  117±3 2.0±0.2 0.911 
SGF-SIF 45.1±0.7 34.9±2.6 0.966  151±4 9.4±2.0 0.883 
 
For all the tablets, the axial swelling was much higher than the radial swelling, and the 
rate constant along axial direction is an order of magnitude higher (Table 4.1). As expected, 
the CHAS tablets did not show any pH effect, but ionic strength influenced the swelling. 
Thus, the dimensions of the swollen tablets in both SGF and SIF are smaller than those in 
distilled water (65 vs. 90% radially and 100 vs. 130% axially). An increase in the ionic 
strength causes a decrease in the osmotic pressures (due to hydration of ionic species), 
leading to a reduction of swelling. For the other three matrices, i.e, CMS, chitosan and the 
complex, the effect of pH was more significant than that of ionic strength (Figure 4.3 C-F). 
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The swelling of the CMS tablets was lower in SGF than in neutral media due to the 
protonation of the COOH groups. In SGF-SIF, the tablets swelled to a similar extent as in 
SGF. Differently, the swelling of the complex tablets in SGF was almost twice of those in 
other media (Table 4.1). The tablets in distilled water had the solid-like appearance due to a 
very slow swelling process. The outer gel layer of CMS-chitosan tablets was thicker than that 
of a CMS tablet, but water diffusion was slower in its core (Figure 4.1). According to the 
swelling characteristics, drug could be released in a controlled way by the complex after an 
initial burst dissolution of the drug located near the surface of a tablet.  
The in vitro dissolution experiments of monolithic tablets made of the complex loaded 
with 20 wt% aspirin showed a sustained release up to 30 hours, longer than expected.30 By 
contrast, 90% of the loaded aspirin was released in about 11 hours when CMS or chitosan 
alone was used as the excipient.30 Aspirin has a water solubility of 4.6 mg/mL37 and its pKa is 
3.5. The relatively long sustained drug release of aspirin from the complex tablets can be a 
result of a binding interaction with either CMS or chitosan in acidic and neutral media, 
respectively. During the first two hours in SGF, the hydrogen bonding among the carboxyl 
acid groups of aspirin and CMS slowed down the drug release. In SIF, the interaction 
between aspirin and chitosan may become more predominant than the hydrogen bonding in 
the system, reducing the diffusion rate of aspirin out of the hydrated membrane of the matrix. 
In the case of acetaminophen,30 a drug with slightly higher water solubility (14 mg/mL)37 and 
with higher pKa (9.4), the best release was afforded by chitosan excipient alone due to a 
possible interaction between acetaminophen and chitosan in the physiological media. The 
CHAS tablets showed a similar release profile of acetaminophen to those of complex.26, 30 
 
4.5. Conclusion 
Both CMS and chitosan have demonstrated pH-dependent swelling capabilities. The 
tablets made of the complex of CMS and chitosan presented a combined benefit of a lower 
swelling in acidic media than those of chitosan alone and a slower water uptake than CMS in 
neutral media. A considerable decrease in swelling (60% radially and 150% axially) in 
neutral media is observed by NMRI for the complex tablets in comparison with those of CMS 
and chitosan. Similar to CHAS, the complex tablets can keep their integrity after the tablet 
swelling reaches an equilibrium. The interaction between the carboxyl groups of CMS and 
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amine groups of chitosan showed a similar stabilizing effect as hydrogen bonding in the case 
of covalent cross-linked starch. The in-vitro dissolution experiments presented a particularly 
slow release of aspirin from the monolithic tablets with 20 wt% drug loading.30 The results 
showed that the complex of CMS and chitosan is a promising polymer excipient for sustained 
drug release, by partially retaining the gastroprotective effect of CMS and by modulating its 
solubility in neutral media through ionic association with chitosan. This behaviour makes the 
novel complex a good excipient to colon delivery. Its swelling properties may be modulated 
by pH and ionic strength of the processing medium and the molar ratio of the two 
components. 
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4.7. Supporting Information 
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Figure 4.4. The NMR images of the CHAS tablets immersed in various media at 37oC for 1, 
2, 5, 7, 10 and 15 h. The part at the bottom of the images is the Teflon support. The dark spots 
around the tablets are air bubbles.  
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Figure 4.5. The NMR images of the CMS tablets immersed in various media at 37 oC for 1, 
2, 3 and 4 h.  
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Figure 4.6. The NMR images of the chitosan tablets immersed in various media at 37 oC for 
1, 2, 5, 10, 15 and 20 h.  
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Figure 4.7. The change of the proton density profile of the CHAS tablets immersed in (A) 
H2O, (B) SGF, (C) SIF and (D) SGF-SIF at 37 oC.  
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Figure 4.8. The change of the proton density profile of the CMS tablets immersed in (A) 
H2O, (B) SGF, (C) SIF and (D) SGF-SIF at 37 oC. 
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Figure 4.9. The change of the proton density profile of the chitosan tablets immersed in (A) 
SGF and (B) SGF-SIF at 37 oC. 
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Figure 4.10. The radial and axial swelling of the CHAS, CMS and CMS-chitosan complex 
tablets in (A) H2O, (B) SGF, (C) SIF and (D) SGF-SIF. 
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5. Conclusion 
 
Molecular diffusion in hydrogels has been a subject of great importance with respect to 
both fundamental research and practical applications of polymers used for biomedical and 
pharmaceutical applications. Two related NMR techniques, PGSE NMR spectroscopy and 
NMR imaging, have been used to study the characteristics of controlled drug-delivery 
systems based on polymers including PVA, CHAS, CMS, chitosan and CMS-chitosan 
complex. The diffusion properties of small molecules and macromolecules in aqueous 
solutions and gels have been studied and compared. 
 
5.1. The diffusion of Star Polymers in PVA Solutions and Gels 
PGSE NMR spectroscopy has been used to study the diffusion of star-shaped polymers in 
polymer solutions and gels. This technique can be applied easily to measure the self-diffusion 
coefficients of small and large molecules in polymer solutions and gels, especially for certain 
diffusant probes inaccessible to other techniques, such as fluorescence photobleaching 
recovery, confocal fluorescence microscopy and dynamic light scattering. It is a rapid and 
noninvasive method and requires only a small amount of the sample. The results can also 
provide the hydrodynamic radii (RH) of the diffusants, which are related to the structure of the 
molecules. The model of Petit et al. developed in our group also provides a comparison of the 
jump frequencies of different probes in the same polymer gel.  
The experiment is sensitive to thermal convection currents in the sample, so a precise 
temperature control is needed. If the probe molecules have overlapping resonances, they 
could be separated based on the differences among their diffusion coefficients on a 2D 
spectrum (with chemical shift on one axis and the distribution of diffusion coefficients on the 
other axis). But the data processing is much more time-consuming and strongly depends on 
the method and the input data.  
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The diffusion of the star-shaped polymers with a cholic acid core and four PEG arms 
were studied. Their diffusion in aqueous solutions and PVA gels were compared with those of 
other PEG-based macromolecules of linear and dendritic architectures. The results showed 
that the star polymers have an intermediate diffusion rate between the dendrimers and the 
linear PEGs of comparable molecular weight. The diffusion rate is essentially dominated by 
the density of the molecules, which has been shown by the comparisons between linear and 
cyclic PEGs.  
T1 measurements of different moieties of the star-shaped polymers were used to 
determine their conformations in the solutions and the change in mobility with increasing 
concentration. The four PEG arms have a higher mobility than the cholic acid core of the star 
polymers, indicating the star polymers have a similar conformation as the PEG-based 
dendrimers.  
 
5.2. The Study of the Effect of Drug Loading 
NMRI has been used to study selected tablets for controlled drug delivery systems. 
NMRI is a noninvasive and effective method to record the dynamic change of the tablets. 
NMRI typically observes the mobile 1H associated with free water, whereas the fast decaying 
1H nuclei associated with polymer network and bound water are mostly invisible due to their 
short T2 values. The dimensional change of a tablet immersed in a medium is given by the 
images acquired at predefined intervals. By integration of the proton intensity profiles, the 
liquid uptake may be obtained, which gives more accurate results than the commonly-used 
weighing method. Moreover, diffusion-weighted imaging provides diffusion coefficients 
explicitly, which can be used to probe the microscopic spatial heterogeneity of a polymer 
network.  
The effect of drug loading on the swelling was studied with the CHAS tablets loaded 
with different amounts of acetaminophen (10, 20 and 40 wt%). The study showed that the 
presence of drug molecules accelerated water uptake due to the changes in the chemical 
potential gradient. The higher drug loading led to faster water diffusion into the tablet. The 
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drug solubility and the degree of drug loading have little influence on the diffusion coefficient 
of water in the outer membrane formed at the interface of the bulk water and the tablets. 
Inside the tablets, water diffuses faster for tablets with higher drug loading and increases 
gradually with time.  
Despite the different rates of water uptake and diffusion in the tablets, the percentage of 
the drug released remained similar for all the CHAS tablets. The outer membrane ensured a 
controlled release of acetaminophen, regardless of the amount of drug in the tablet.  
The changes of the water diffusion coefficient and the tablet swelling strongly depend on 
the solubility of the drug and the loading level. The drug releasing rate merely undergoes a 
minor change with increasing drug loading amount. Compared to the CHAS tablets with no 
drug loaded, the tablets of 10 – 40 wt % acetaminophen swell substantially faster. The matrix 
is able to keep the integrity of all the tablets after their immersion in water for long time. 
 
5.3. The Study of Various Polymer Matrices 
The swelling of the CHAS tablets were compared with the tablets made of 
polyelectrolyte matrices including chitosan, CMS and CMS-chitosan complex in both acidic 
and neutral media. Simulated physiological liquids (SGF and SIF) were used for the in vitro 
study of the swelling and drug dissolution of the tablets. In the case of SGF, some artifacts 
appeared on the NMR images due to the relatively high ionic strength of SGF. 
The tablets made of chitosan, CMS, and the CMS-chitosan complex showed pH-sensitive 
swelling due to the presence of –COONa and/or –NH2 functional groups. The CMS-chitosan 
complex tablets have similar swellings to those of CHAS tablets in neutral media. But the 
complex tablets in SGF showed a greater extent of swelling. The remarkable dimensional 
change in SGF is mainly contributed by chitosan that is dissociated from CMS.  
The effect of pH is more pronounced than that of the ionic strength for the tablets without 
drug loading. The swelling in various pH depends on the pKa of the matrix. In the case of 
drug-loaded tablets, the drug release rate is affected by the pKa values of both the matrix and 
the drug rather than the drug loading level.  
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5.4. Future Work 
5.4.1. Research Techniques 
In the NMRI studies of polymer matrices, a more precise definition of the penetration 
front may be useful. The front is currently defined by proton density profiles taken from the 
NMR images. However, very low water content may not be detectable by NMRI due to their 
short spin-spin relaxation times (T2). This may be improved by T2 imaging of the tablets 
combined with 1D imaging. In addition, a theoretical NMR signal intensity profile may be 
obtained when T1 and T2 have been measured. The use of theoretical rather than the apparent 
NMR signal intensity also make the definition of the glassy core more precise, which can be 
compared with the experimental determination of swelling and penetration fronts. 
A NMRI coupled with a dissolution system may be built to acquire images while drug 
release is measured simultaneously. A study of tablet dissolution and the subsequent drug 
release would be useful if the study is carried out under controlled conditions with flow or 
another form of agitation. A common practice is to incorporate a flow-through cell inside the 
bore of the magnet. UV-vis spectroscopy or HPLC may be employed to measure the total 
drug release. 
 
5.4.2. Choice of Diffusing Probes 
A series of hydrophilic PEG star polymers without a hydrophobic core may be studied in 
terms of their diffusion properties in aqueous solutions and PVA gels. By comparing these 
diffusants with those having been studied, including the linear, dendritic PEGs and the star 
polymers with a cholic acid core, the effect of the core on the diffusion of the polymeric 
probes may be better elucidated, leading to a better understanding of the effect of polymer 
architecture.  
Complexation between oppositely charged polyelectrolytes proved to be a promising 
method to prepare microspheres for drug delivery applications. However, the dissociation of 
the anionic and cationic polymers in gastric media might occur due to the reversibility of the 
cross-linking by electrostatic interactions, which usually causes an undesired fast release of 
the loaded drug in the stomach. In the case of the chitosan complexes, the rate of the swelling 
and erosion of the tablets in SGF has been reduced with respect to chitosan itself, but the 
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complex showed little effect on slowing down the release in SGF. An accurate control of the 
complex preparation process, such as pH, ionic strength of the media, order of mixing of the 
components may modify the complex formulation in the acidic environment. The second 
route to improve the performance of the complex in SGF is to prepare the complex of CMS 
and chitosan with increased negative charge density.  
 
5.4.3. Choice of Drugs 
The release of the drugs with low and intermediate solubilities (ciprofloxacin and 
acetaminophen) has been studied in the solid dosage forms of CHAS. The limited swelling 
and compact feature of the CHAS tablets showed a strong capacity to control the release of 
those drugs. Other drugs with higher solubilities could be tested to check the upper loading 
limit of the CHAS tablets. These drugs may include amoxicillin trihydrate (solubility ca. 3500 
mg/L) and the highly soluble metformin. 
The release of the drugs of intermediate and high solubilities (aspirin, acetaminophen and 
metformin) has been studied with the chitosan-CMS complex as the carrier. The complex 
tablets with acetaminophen (pKa 9.4) loaded had 80% of drug released within 7 hours 
(chapter 4). In the case of aspirin (pKa 3.5), however, the duration was significantly 
prolonged to over 20 hours (chapter 4). Although the drug release is difficult to control in 
gastric fluid by the chitosan-CMS complex, a drug insoluble in acidic media, such as 
diclofenac (solubility ca. 50 mg/mL, pKa 4.15), may benefit from the formulation. Diclofenac 
bears a carboxyl acid group which may interact with dissociated chitosan in the solution of 
low pH, probably causing a delayed release. 
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Appendix 
Pharmaceutical Polysaccharides: Pectin, Alginate, and Carrageenan 
 
Pectin, an anionic polysaccharide, is extracted from citrus fruit and apple pomace. It 
consists primarily of chains of galacturonic acid units (which can be randomly acetylated and 
methylated) linked as 1,4-α-glucosides (Figure A1). It is soluble in water.  
 
O
HO
OH
R
O
n
R= COOH or COOCH3  
Figure A1. The chemical structure of pectin. 
 
Chitosan can act as an effective crosslinker of pectin networks under slightly acidic 
conditions. Gelation behaviour is dependent on the degree of esterification of the pectin and 
concentration of the crosslinker.1 Zero-order kinetics was achieved using a binary polymer 
matrix consisting of highly methoxylated pectin and HPMC at different ratios (4:5, 3:6, and 
2:7), both in the case of soluble and poorly soluble drugs,  as a result of rapid 
hydration/gelation in both axial and radial directions.2  
Widely used in food industry as a gelling agent and a stabilizer, pectin has been approved 
by USFDA as an inactive ingredient in oral tablets and capsules.3  
Alginates are polysaccharide polymers isolated from brown seaweed. Alginate (Figure 
A2) is a linear copolymer composed of 2 monomeric units, D-mannuronic acid (M) and L-
guluronic acid (G). The monomers can appear in homopolymeric blocks of consecutive G-
residues, consecutive M-residues, alternating M and G-residues, or randomly organized 
blocks. The pKa values for mannuronic and guluronic acid monomers are 3.38 and 3.65, 
respectively.4 
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Figure A2. The chemical structures of G and M blocks of alginate. 
 
Monovalent metal ions form soluble salts with alginate whereas divalent and multivalent 
cations (except Mg2+) form gels or precipitates. The calcium alginate gels have been 
extensively studied. The fast drug release of Ca2+-alginate based systems  can be improved by 
modifying the microsphere surface using polycations (chitosan/poly-L-lysine).5 Alginate may 
form an acid gel and an ionotropic gel dependent on pH. The physicochemical properties of 
the polymer system and the swelling process are dependent on the type of gel formed.6 
Alginate-chitosan-based drug delivery systems provide a striking improvement in the 
pharmacokinetic parameters.7 The preparation of alginate-chitosan microspheres involves the 
cation-induced gelation of alginate, useful for the simultaneous encapsulation of the drug. 
Ammonium calcium alginate, propylene glycol alginate, and sodium alginate have been 
approved by USFDA for using as inactive ingredients in oral tablets and capsules.3 
Carrageenan is an anionic polysaccharide which is extracted from red seaweed. It 
consists of potassium, sodium, calcium, magnesium, and ammonium sulfate esters of 
galactose and 3,6-anhydrogalactose copolymers. It is soluble in water at 80oC. The 
carrageenans are divided into three families (κ-, ι-, and λ-carrageenan) according to the 
position of sulfate groups and the presence or absence of anhydrogalactose (Figure A3). The 
gelling ability becomes weaker in the order of κ-, ι-, and λ-carrageenan which possesses one, 
two, and three sulfate groups, respectively. Tablets based on carrageenan exhibit sensitivity to 
the pH and ionic strength of the media.8 A study showed that the chitosan-alginate mixture 
could form hydrogel without disrupting the microstructure due to the high elastic modulus of 
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the swollen tablet, while tablets prepared from the chitosan-carrageenan mixture underwent a 
fast water uptake and a severe erosion process, leading to a less controlled drug release in 
acidic media (pH 1.2).4 The difference was caused by the formation of polyelectrolyte 
complex due to the electrostatic bond between amino groups of chitosan and sulfonate groups 
of carrageenan. The interaction can only occur at pH values in the vicinity of the pKa interval 
of the two polymers.4 Alginate is un-ionized at pH 1.2 and thus no complexation can occur 
between alginate and chitosan.  
Carrageenan, calcium carrageenan, and sodium carrageenan have been approved by 
USFDA for using as inactive ingredients in oral tablets and capsules.3  
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Figure A3. The chemical structures of (A) κ-carrageenan, (B) ι-carrageenan, and (C) λ-
carrageenan 
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